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Abstract		This	 thesis	 consists	 of	 two	 different	 works	 developed	 on	 two	 distinct	 research	themes,	both	of	them	included	in	the	broader	issue	of	bacterial	virulence.		The	first	part	concerns	the	molecular	characterization	of	the	heat-shock	regulatory	circuit	 in	 the	 food-borne	pathogen	Campylobacter	 jejuni.	 The	heat-shock	 response,	being	 cellular	 damage	 protection	 mechanism,	 is	 involved	 in	 the	 establishment	 of	successful	 infections	 in	 different	 bacteria.	 Moreover,	 in	 C.	 jejuni,	 this	 regulatory	circuit	 emerged	 as	 a	 crucial	 pathway	 for	 the	 shift	 between	 commensalism	 and	pathogenicity	in	different	hosts,	tanks	to	the	peculiarity	to	modulate	host-pathogen	interactions.	 This	 evidence	 makes	 the	 heat-shock	 circuit	 characterization	indispensable	 to	 elucidate	 the	 molecular	 basis	 of	 C.	 jejuni	 pathogenicity	 and	virulence.		The	 second	 section	 is	 inherent	 to	 urease	 activity	 in	 the	 presence	 of	 gold-based	compounds.	 The	 urease	 enzyme	 is	 a	 virulence	 factor	 for	 different	 pathogenic	bacteria,	 of	 which	 Helicobacter	 pylori,	 Mycobacterium	 tuberculosis,	 Cryptococcus	
neoformans,	Yersinia	pestis,	and	Proteus	mirabilis.	This	peculiarity	makes	the	urease	an	interesting	target	for	potential	new	specific-drugs	against	ureolytic	pathogens.	
Characterization	of	the	heat-shock	regulatory	circuit	in	C.	jejuni	The	 heat-shock	 response	 is	 a	 mechanism	 of	 cellular	 protection	 that	 triggers	 a	sudden	 increase	 in	 the	 cellular	 concentration	 of	 different	 proteins,	 including	molecular	 chaperones	 and	 proteases.	 This	 response	 entails	 protection	 against	protein	folding	that	is	damaged	by	the	stress	conditions.	In	the	human	pathogen	C.	
jejuni,	the	response	to	thermic	stress	is	controlled	by	a	regulatory	circuit,	which	acts	at	 the	 transcriptional	 level	 and	 involves	 the	 repressors	 HspR	 and	 HrcA.	 To	characterize	 the	 molecular	 mechanism	 underpinning	 HspR	 and	 HrcA	 regulatory	function,	 we	 investigated	 in	 detail	 the	 HspR	 and	 HrcA	 interactions	 with	 their	operator	 sites	 by	 DNase	 I	 footprinting	 assays.	 These	 analyses	 allowed	 the	identification	of	 their	 binding	 sites,	 and	highlight	 a	 complex	 architecture	 resulting	from	protein-DNA	interactions.	More	in	detail,	the	binding	architecture	is	composed	
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of	 multiple	 HspR-recognition	 sites	 located	 in	 a	 singular	 promoter,	 added	 to	 the	HrcA-binding	 element	 on	 co-regulated	 promoters.	 Moreover,	 our	 results	 indicate	that	 HspR	 interacts	 cooperatively	 with	 high	 and	 low-affinity	 DNA	 binding	 sites	mapping	on	each	promoter.	To	elucidate	the	role	of	 this	complex	DNA-binding,	we	tested	the	HspR	binding	ability	to	several	DNA	probes	harbouring	mutations	within	the	 target	 sequences.	 We	 also	 explored	 the	 DNA-binding	 properties	 of	 HspR	 and	HrcA	 competitively	 on	 their	 common	 targets	 and	 observed	 for	 the	 first	 time	 that	each	regulator	has	a	positive	effect	on	DNA-binding	ability	of	the	regulatory	partner.	This	mutual	cooperative	effect,	of	HspR	and	HrcA,	on	DNA	binding	could	explain	the	synergic	 repressive	 impact	of	 the	 two	repressors	observed	 in	vivo	 on	 co-regulated	promoters.	
Urease	inactivation	by	gold-based	compounds	Urease	is	an	enzyme	that	plays	a	crucial	role	as	virulence	factor	in	the	pathogenesis	of	 different	 microorganisms.	 In	 this	 work,	 we	 analysed	 the	 inhibition	 ability	 of	different	 gold-based	 compounds	 on	 urease,	 investigating	 the	 potentiality	 of	 these	compounds	as	future	antimicrobials	in	ureolytic	bacteria.	We	implemented	different	enzymatic	 assays	 allowed	 to	 kinetically	 characterize	 the	 inhibitory	 activity	 of	 the	Au(III)-complexes,	 and	 revealing	 their	 ability	 to	 inactivate	 the	 enzyme	 in	 the	 low	nanomolar	 concentration	 range.	 Moreover,	 our	 results	 permitted	 to	 elucidate	 the	inhibition	modality	 of	 these	 compounds,	 which	 resulted	 based	 on	 a	 slow-binding	mechanism	requiring	the	two-isomerization	steps.								
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Introduction		
1.1 Campylobacter	jejuni		
Campylobacter	 jejuni	 (Fig.1)	 is	 a	 Gram-negative,	 microaerophilic,	 spiral,	 and	flagellated	bacterium	belonging	to	the	delta-epsilon	group	of	proteobacteria,	 in	the	order	Campylobacteriales,	including	also	the	genera	Helicobacter	and	Wolinella.		
																																																							 	
Figure	 1:	 Scanning	electron	micrograph	of	C.	jejuni	 clinical	 strain	M129	with	an	INT	407	epithelial	cell.	Adapted	from	WSU	School	of	molecular	biosciences	Konkel	&	colleagues.		
1.1.1 Epidemiology			
C.	 jejuni	 is	 the	 leading	 cause	of	bacterial	 food-borne	diarrhoeal	disease	worldwide	(Blaser,	 1997),	 accounting	 for	 more	 infection	 than	 Escherichia	 coli	 O157:H7,	
Salmonella	spp.	and	Shigella	spp.	(Apel,	Ellermeier,	Pryjma,	DiRita,	&	Gaynor,	2012).	While	most	cases	of	gastroenteritis	associated	with	C.	jejuni	infection	are	generally	self-limiting,	it	is	also	linked	to	severe	post-infection	complications,	such	as	Gullian-Barré	syndrome,	a	demyelinating	polyneuropathy	causing	bilateral	paralysis	(Nyati	&	 Nyati,	 2013).	 	 Although	 C.	 jejuni	 is	 a	 human	 pathogen,	 it	 can	 colonize	 in	 an	asymptomatic	 manner	 the	 gastrointestinal	 tract	 of	 different	 animals,	 including	chicken	and	other	avian	species.	This	ability	is	at	the	root	of	its	contamination	cycle,	where	 contaminated	 water	 and	 unpasteurized	 milk	 or	 meat,	 especially	 poultry,	
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serve	as	C.	jejuni	reservoirs,	and	it	is	a	source	for	human	infection	(Young,	Davis,	&	DiRita,	2007).	
1.1.2 Pathogenicity		Throughout	 the	 establishment	 of	 an	 infection,	 bacteria	 must	 overtake	 the	mechanical	 and	 immunological	 barriers	 of	 the	 gastro-intestinal	 tract.	 C.	 jejuni	succeeds	 in	bypassing	 the	mucus	 layer	of	 the	gastro-intestinal	epithelium,	 the	 first	defence	 line,	 because	 of	 its	 motility,	 corkscrew	 morphology,	 and	 of	 an	 unusual	lipooligosaccharide.	 Indeed,	 C.	 jejuni	 lipooligosaccharide	 is	 made	 up	 of	 relatively	short	O-sidechain	 that	may	 reduce	nonspecific	binding	 to	 the	mucin	glycoproteins	(McSweegan	&	Walker,	1986).		After	passing	the	mucus	layer,	C.	jejuni	interacts	with	the	epithelial	host	cells	and	elicits	an	immune	response	that	differs	between	human	and	chicken.	In	humans,	C.	jejuni	can	interact	with	the	epithelial	cells	both	through	external	bond	and	internalization	by	the	cells.	These	interactions	cause	interleukin	(IL)-8	production	and	induce	the	recruitment	of	dendritic	cells	and	the	subsequent	interaction	 of	 macrophages	 and	 neutrophils	 with	 the	 bacterial	 cells.	 The	 C.	 jejuni	interactions	 with	 human	 cells	 trigger	 a	 massive	 pro-inflammatory	 response	associated	 with	 an	 increase	 of	 the	 cytokines	 (Young	 et	 al.,	 2007).	 Dissimilarly,	 in	chicken	 C.	 jejuni	 stimulates	 the	 production	 of	 IL-1β,	 IL-6,	 and	 intracellular	 nitric	oxide	synthase	by	epithelial	cells	and	macrophages,	without	leading	the	pathological	inflammatory	response.	This	peculiarity	allows	colonizing	chicken	in	high	numbers.	Various	 factors	 may	 reduce	 or	 redirect	 the	 chicken	 immune	 response	 towards	tolerance;	heterophils	and	macrophages	might	also	have	a	 role,	whereas	epithelial	cell	invasion	is	not	reported	(Young	et	al.,	2007).			
1.1.2.1 Flagella	and	chemotaxis	in	C.	jejuni	pathogenicity			Among	 the	 different	 C.	 jejuni’s	 elements	 that	 allow	 it	 to	 establish	 a	 successful	infection,	an	essential	role	is	exerted	by	the	flagella	and	flagellar	motility,	which	are	involved	 in	host	colonization,	virulence,	host-cell	 invasion	and	secretion	(Young	et	al.,	2007).	The	chemotaxis	 seems	 to	play	a	 crucial	 role	both	 in	 commensalism	and	pathogenicity	in	C.	jejuni.	Indeed,	mutations	of	the	chemotactic	genes	affect	chicken	colonization,	as	well	as	virulence	 in	pathogenic	hosts	 (Hendrixson	&	DiRita,	2004)	
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(Yao,	Burr,	&	Guerry,	1997).	Besides,	C.	jejuni	displays	chemotactic	motility	towards	components	of	 the	mucus	and	amino	acid	 found	 in	 the	 chick	gastrointestinal	 tract	(Hugdahl,	Beery,	&	Doyle,	1988).		
1.1.2.2 Cytolethal	distending	toxin		
C.	 jejuni,	 like	 other	 bacterial	 species,	produces	 cytolethal	 distending	 toxin	 that	 is	linked	 with	 the	 double-strand	 DNA	 brakes	 and	 the	 arrest	 of	 the	 cell	 cycle	 (Lara-Tejero	 &	 Galan,	 2000)(Hassane,	 Lee,	 &	 Pickett,	 2003).	 	 The	 cytolethal	 distending	toxin	 is	 expressed	booth	 in	 chicken	 and	 in	 human,	 but	 in	 chicken	were	not	 found	neutralizing	antibody	agaist	the	toxin,	highlighting	a	variance	in	the	recognition	way	by	the	two	hosts	(Young	et	al.,	2007).	
	
1.1.2.3 Heat-shock	response	in	C.	jejuni	pathogenicity		An	 interesting	difference	between	chicken	and	mammals,	 including	humans,	 is	 the	body	temperature,	42	°C	in	chicken,	and	37	°C	in	human.	This	difference	could	make	the	 temperature	a	potential	 signal	 for	host-specific	 infection,	and	 in	 turn	 the	heat-shock	 response	 a	mechanism	 able	 to	 promote	 the	 switch	 between	 commensalism	and	pathogenicity	(Apel	et	al.,	2012)	(Young	et	al.,	2007).	Generally,	the	heat	shock	response	 plays	 a	 central	 role	 in	 host-pathogen	 interaction	 of	 different	 bacteria	species	as	a	mechanism	of	 cellular	protection	able	 to	preserve	 the	protein	 folding,	which	is	damaged	by	the	stress	conditions	encountered	during	the	establishment	of	an	infection.	This	makes	different	heat-shock	proteins	virulence	factors	or	elements	that	 contribute	 to	 pathogenesis	 in	 an	 indirected	 manner	 (Roncarati	 &	 Scarlato,	2017).	 In	C.	jejuni,	 the	heat-shock	 response	 is	mediated	by	 the	 two	 transcriptional	repressors,	HspR	and	HrcA	 (Andersen	et	al.,	 2005)	 (Holmes,	Penn,	&	Lund,	2010),	which	 repress	 transcription	 of	 the	 heat-shock	 genes	 at	 low	 temperature,	 37	 °C.	Another	 regulatory	 system	 that	 might	 be	 involved	 in	 the	 survival	 at	 high	temperature	is	the	RacR/RacS	two-component	system.	This	system	also	responds	to	different	 environmental	 conditions	 encountered	during	 infection,	 but	 independent	of	 the	temperature	switch	(Apel	et	al.,	2012).	 Interestingly,	 the	deregulation	of	 the	heat-shock	proteins,	 the	 transcriptional	 repressors	HspR	and	HrcA,	and	 the	RacRS	system	is	linked	to	an	altered	bacterial	length	causing	an	elongation	of	the	cell.	This	
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phenotype	is	also	connected	to	motility	defects,	and	consequently,	to	a	deficiency	in	epithelial	cell	invasion.	This	motility	deficiency	is	caused	by	filamentation	of	the	cells	and	does	not	involve	defects	in	the	flagellar	apparatus	(Andersen	et	al.,	2005)	(Apel	et	al.,	2012).		
1.1.2.4 Genetic	variation	and	natural	transformation		Other	 C.	 jejuni’s	 elements	 relevant	 to	 its	 pathogenicity	 are	 the	 extensive	 genetic	variation	 and	 the	 natural	 transformation.	 Intriguingly,	 the	 majority	 of	 the	hypervariable	 sequences	 are	 in	 regions	 encoding	 proteins	 associated	 with	 the	production	 and	 modification	 of	 the	 surface	 structure,	 and	 involved	 in	 immune	avoidance,	virulence,	secretion	and	invasion	of	host	cells.	This	class	includes	capsule,	surface	 polysaccharide,	 lipooligosaccharide,	 and	 flagellar	 genes	 (Parkhill	 et	 al.,	2000)(Linton	 et	 al.,	 2000)(Young	 et	 al.,	 2007).	 Moreover,	 C.	 jejuni	 is	 naturally	competent	and	can	take	up	DNA	from	the	environment.	That	leads	to	recombination	between	 strains,	 allowing	 the	 generation	 of	 high	 genetic	 diversity.	 The	 horizontal	transfer	 of	 both	 plasmid	 and	 chromosomal	 DNA	 occurs	 both	 in	 vitro	 and	 during	chick	 colonization,	 indicating	 that	 natural	 transformation	 could	 play	 an	 important	role	 in	genome	plasticity	and	in	the	spread	of	new	genetic	tracts	such	as	antibiotic	resistance,	even	 in	 the	absence	of	selective	pressure	(De	Boer	et	al.,	2002)(Avrain,	Vernozy-Rozand,	&	Kempf,	2004)(Young	et	al.,	2007).				
1.1.3 C.	jejuni	genome		
C.	jejuni	has	a	genome	of	approximately	1600	kb	in	size.	The	genome	analysis	of	C.	
jejuni	NCTC11168	strain	predicted	the	existence	of	1654	protein-coding	genes	and	54	stable	RNA	species	(Parkhill	et	al.,	2000).	Its	genome	compared	to	the	genome	of	the	 closely	 phylogenetic	 related	 microorganism	H.	 pylori	 shows	 strong	 similarity,	which,	 however,	 is	 exclusively	 restricted	 to	 housekeeping	 functions.	 Indeed,	 just	55.4%	of	C.	jejuni	genes	show	an	orthologous	in	H.	pylori	(Parkhill	et	al.,	2000).			
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Figure	 2:	 Coding	 sequences	 transcribed	 in	 the	 clockwise	 direction	 (dark	green),	and	coding	sequences	in	the	anticlockwise	direction	(pale	green).	It	 is	marked	 the	 putative	 origin	 of	 replication.	 In	 black	 the	 positions	 of	hypervariable	sequences	are	highlight.	The	genes	involved	in	the	production	of	surface	structures	are	marked	(clockwise	in	dark	red	and	anticlockwise	in	pale	red).	The	similarity	of	each	gene	to	its	H.	pylori	orthologue	is	indicated	by	the	height	of	the	bar	and	the	intensity	of	the	colour.	Adapted	from	Springer	Nature,	License	Number:	4698690911335	(Parkhill	et	al.,	2000).			As	H.	pylori,	the	C.	jejuni	genome	sequence	shows	a	low	G+C	content	of	30.6%	with	two	 large	 regions	 including	 the	 portion	 for	 the	 lipooligosaccharide	 and	 the	extracellular	 polysaccharide	 biosynthesis	 cluster,	 where	 the	 G+C	 content	 drops	down	 to	 25.4%	 and	 26.5%,	 respectively	 (Parkhill	 et	 al.,	 2000).	 The	 higher	 A+T	content	maps	in	the	proximity	of	promoter	regions.	Analysis	of	these	regions	carried	out	 in	 different	 C.	 jejuni	 strains	 showed	 an	 extended	 -10	 box	 with	 an	 upstream	periodic	 A/T-rich	 pattern	 as	 a	 consensus	 motif	 in	 89%	 of	 the	 promoters.	 The	relationship	 between	 this	 A/T-rich	 region	 and	 their	 relevance	 in	 transcription	initiation	 is	 also	 confirmed	 by	 the	 identification	 of	 several	 examples	 of	 disruptive	single-nucleotide-polymorphisms	(SNPs)	in	the	A/T-rich	region	(Dugar	et	al.,	2013).	An	 A/T-rich	 sequence	 followed	 by	 the	 AAGGA-motif	 is	 also	 detected	 as	 the	consensus	sequence	for	the	ribosome	binding	site.	Highlighting	the	relevance	for	the	A/T-rich	pattern	even	in	the	mRNA	translation	(Dugar	et	al.,	2013).			
C.	 jejuni	 is	 predicted	 to	 code	 for	 a	 higher	 number	 of	 regulatory	 proteins	 than	H.	
pylori,	although	a	similar	genome	size.	Likely,	this	may	be	due	to	a	higher	number	of	
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ecological	 niches	 colonized	 by	 C.	 jejuni	 (Parkhill	 et	 al.,	 2000).	 As	H.	 pylori,	 also	 C.	
jejuni	 displays	only	 three	 sigma	 factors,	 the	housekeeping	σ70,	 and	 two	alternative	σ54	 and	 σ28	 sigma	 factors,	 which	 regulate	 the	 expression	 of	 many	 flagellar	 genes	(Carrillo	et	al.,	2004)	(Dugar	et	al.,	2013).	In	contrast,	the	more	significant	portion	of	regulatory	factors	belongs	to	the	two-component	regulatory	systems	(Parkhill	et	al.,	2000).	A	peculiar	 feature	of	C.	jejuni	 is	represented	by	a	high	frequency	of	genome	variation,	 provided	 by	 the	 high	 number	 of	 hypervariable	 sequences.	 Intriguingly,	this	 variability	 may	 be	 linked	 with	 slipped-strand	 mispairing	 in	 the	 proximity	 of	homopolymeric	tracts	during	the	replication,	and	probably	linked	to	the	absence	of	several	E.	coli	DNA-repair	genes	homologues.	The	high	levels	of	variation	observed	in	 the	 shotgun	 sequences	denote	 that	 it	 is	 not	possible	 to	build	 a	 single	definitive	sequence	 for	 the	C.	 jejuni	 genome.	As	 such,	 it	 possesses	 some	of	 the	 properties	 of	quasi-species;	 a	 phenomenon	 that	 is	 well	 described	 in	 RNA	 viruses	 (Young	 et	 al.,	2007)	 (Parkhill	 et	 al.,	 2000).	 Another	 peculiarity	 of	 the	 C.	 jejuni	 genome	 is	 the	absence	 of	 functional	 insertion	 sequence	 (IS)	 elements,	 retrons,	 transposons,	 and	prophages,	 except	 for	 the	 Cj0752	 insertion	 sequence	 that	 is	 similar	 to	 IS605	 tnpB	from	 H.	 pylori	 (Parkhill	 et	 al.,	 2000).	 The	 absence	 of	 these	 elements	 seems	 to	correlate	 with	 the	 presence	 of	 a	 type-II	 CRISPR/Cas	 system.	 Indeed,	 strains	 that	display	degenerated	CRISPR	loci	frequently	show	plasmids	and	integrated	elements	(Dugar	et	al.,	2013).		
	1.2	Regulatory	systems				Generally,	bacteria	react	to	changes	in	environmental	conditions	or	the	intercellular	state,	 re-modulating	 the	expression	of	genes	 that	code	 for	proteins	 involved	 in	 the	adaptation	to	the	new	state.	This	response	is	commonly	mediated	by	transcriptional	regulatory	circuits,	which	are	switched	on	by	sensors	upon	detection	of	the	signals.	The	active	sensors	are	able	to	transduce	the	signals	to	transcriptional	 factors.	This	produces	a	change	 in	 the	regulators	ability	 to	directly	 interact	with	DNA	sequence	on	 target	promoters	 to	activate	or	repress	genes	 transcription	(Perez	&	Groisman,	2009).	These	regulatory	patterns	are	bundled	in	densely	connected	networks	able	to	modulate	the	cellular	response	by	interconnecting	several	stimuli	and	producing	an	
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accurate	 output	 suitable	 for	 the	 specific	 condition	 (Seshasayee,	 Bertone,	 Fraser,	&	Luscombe,	2006).		
1.2.1	The	heat-shock	circuit			The	heat	 shock	 response	 is	 a	mechanism	of	 cellular	protection	 that	 implicates	 the	production	 of	 different	 heat-shock	 proteins,	 as	 chaperone	 and	 proteases,	 able	 to	prevent	 the	 accumulation	 and	 the	 consequent	 aggregation	 of	 denatured	 proteins,	which	occurs	during	stress	conditions,	and	avoid	a	toxic	effect	on	the	cell	(Roncarati	&	 Scarlato,	 2017).	 Although	 the	 heat-shock	 response	 is	 a	 universal	 phenomenon	observed	 in	 all	 studied	 bacterial	 species,	 microorganisms	 do	 not	 use	 a	 unique	regulatory	 strategy.	 Indeed,	 they	have	evolved	various	mechanisms	based	on	both	transcriptional	 and	posttranscriptional	 regulation,	 and	 involving	both	positive	and	negative	mechanisms	of	regulation	(Roncarati	&	Scarlato,	2017).		A	 classic	 example	 of	 heat-shock	 circuit	 is	 the	Escherichia	 coli	 positive	mechanism	that	 combines	 a	 transcriptional	 and	 translational	 regulation.	 E.	 coli	 uses	 two	alternative	 sigma	 factors,	 one	 of	 them,	 RpoH,	 is	 able	 to	 interact	 with	 RNA	polymerase	core	enzyme	and	direct	the	proteins	complex	to	the	promoter	region	of	the	 heat-shock	 genes,	 recognizing	 specific	 DNA	 sequences	 located	 in	 these	promoters	(Sharp	et	al.,	1999)	(Kumar	et	al.,	1995).	 In	 this	system,	 the	heat-shock	response	is	activated	by	the	increment	in	the	amount	of	the	RpoH	alternative	sigma	factor	 in	 response	 to	 temperature	 increase.	 Indeed,	 the	 rpoH	 mRNA	 region	 that	includes	 the	 ribosome-binding	 site	 and	 the	 AUG	 start	 codon	 acquires	 a	 complex	secondary	 structure	 with	 high	 stability	 at	 low	 temperatures.	 This	 peculiar	mRNA	conformation	 hinders	 the	 recruitment	 of	 the	 translation	 machinery	 and	 the	consequent	translation	of	the	rpoH	messanger.	At	42	°C,	a	partial	misfolding	of	the	
rpoH	mRNA	secondary	structure	occurs	and	allows	the	assembling	of	the	ribosome	and	 the	 consequent	 efficient	 translation	 of	 the	 sigma	 factor	 (Morita	 et	 al.,	 1999).	Moreover,	 also	a	post-translational	 regulatory	mechanism	monitors	 the	amount	of	the	available	RpoH	protein	to	enhance	transcription	of	the	heat-shock	genes.	Indeed,	in	 the	 absence	 of	 denatured	 protein,	 different	 chaperons	 can	 interact	 with	 the	alternative	 sigma	 factor	and	sequester	 it.	Whereas,	when	 the	amount	of	misfolded	
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proteins	 increase,	 the	 chaperones	 are	 recruited	 by	 denatured	 polypeptides,	 and	release	the	sigma	factor	(Tomoyasu,	Ogura,	Tatsuta,	&	Bukau,	1998).	In	addition	to	this	chaperon’s	sponge	effect	towards	the	available	RpoH,	chaperon	systems	seem	to	play	 a	 crucial	 role	 in	 promoting	 protease-mediated	 degradation,	 fundamental	 to	decrease	the	alternative	sigma	factor	stability	and	re-establish	the	steady-state	level	(Roncarati	 &	 Scarlato,	 2017).	 Although	 most	 gram-negative	 bacteria	 exploit	 an	alternative	sigma	factor,	other	bacteria,	among	which	C.	jejuni	and	H.	pylori,	evolved	an	 opposite	 strategy	 to	 control	 chaperone	 genes’	 expression,	which	 is	 based	 on	 a	dedicated	repressor	system.	So	at	37	°C,	the	transcription	of	the	heat-shock	genes	is	inhibited	by	the	repressor	binding	to	promoter	regions.	In	contrast,	the	increase	in	temperature	 reduces	 the	 repressor	 affinity	 for	 the	 target	 DNA	 and	 allows	 the	transcription	to	start	(Roncarati	&	Scarlato,	2017).	 It	 is	known	that	the	heat-shock	circuit	 in	 C.	 jejuni	 is	 based	 on	 two	 repressors,	 HrcA	 and	 HspR	 (Andersen	 et	 al.,	2005)(Holmes	 et	 al.,	 2010).	 Although	 a	 molecular	 characterization	 of	 their	 DNA-binding	 activity	 in	 C.	 jejuni	 is	 not	 available,	 there	 is	 a	 variety	 of	 information	 that	came	from	the	HrcA	and	HspR	 investigation	 in	other	bacterial	species.	 In	H.	pylori,	the	HrcA/HspR	circuit	was	previously	characterized,	showing	a	complex	regulatory	network	composed	of	 the	master	regulator	HspR,	which	directly	regulates	another	regulator	(HrcA)	and	a	target	gene	(groESL),	which	in	turn	is	regulated	by	both	HrcA	and	 the	 master	 regulator	 (HspR).	 Moreover,	 considering	 that	 all	 the	 regulatory	interactions	 are	 repressive,	 these	 circuits	 seem	 to	 represent	 rare	 examples	 of	incoherent	type-2	feed-forward	loops	(Danielli,	Amore,	&	Scarlato,	2010)			
1.2.1.1	HrcA		The	HrcA	repressor	protein	was	first	identified	and	characterized	in	Bacillus	subtilis,	where	 it	was	 also	 identified	 the	 cis-element	 CIRCE	 (controlling	 inverted	 repeat	 of	chaperons	expression),	an	inverted	repeat	(IR)	necessary	for	the	binding	of	HrcA	to	the	target	genes	promoters	(A.	Schmidt,	Schiesswohl,	Volker,	Hecker,	&	Schumann,	1992)	 (Schumann,	 Homuth,	 &	 Mogk,	 1998).	 Afterward,	 different	 studies	 tried	 to	obtain	the	biochemical	identification	of	HrcA-CIRCE	interaction	at	a	molecular	level.	Unfortunately,	 this	 characterization	 has	 been	 possible	 only	 in	 H.	 pylori	 and	
Chlamydia	 trachomatis,	 because	 of	 the	 high	 HrcA	 instability	 and	 its	 propensity	 to	
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aggregate	in	insoluble	bodies	(Roncarati,	Danielli,	Spohn,	Delany,	&	Scarlato,	2007)	(Roncarati,	 Spohn,	 et	 al.,	 2007)	 (Wilson	 &	 Tan,	 2004).	 	 The	 available	 information	about	 the	 HrcA	 interaction	 with	 promoters	 shows	 the	 repressor-binding	 region	mapping	close	the	transcription	start	sites.	This	evidence	indicates	that	HrcA	exerts	its	repressive	function	by	interfering	with	the	transcriptional	machinery,	occluding	the	RNA	polymerase	binding	site	on	the	heat-shock	promoters	at	37	°C	(Roncarati	&	Scarlato,	2017).	HrcA	 loses	DNA-binding	affinity	upon	a	 temperature	 increase,	and	releases	the	operator	allowing	the	binding	of	the	RNA	polymerase	and	transcription.	The	 mechanism	 by	 which	 HrcA	 can	 sense	 heat-shock	 conditions	 is	 based	 on	 the	ability	of	the	chaperon	GroE	to	enhance	the	repressor	binding	ability	(Schumann	et	al.,	 1998).	 Indeed,	 this	 GroE	 positive	 effect	 can	 take	 place	 only	 at	 normal	 grow	temperature,	when	the	amount	of	denatured	proteins	is	relatively	low.	By	contrast,	the	 increment	 of	 damaged	 proteins,	 as	 a	 consequence	 of	 the	 stress	 condition,	produces	 chaperon	 recruitment,	 including	 GroE,	 with	 the	 consequent	 stop	 of	 its	HrcA	 stimulating	activity	 (Roncarati	&	Scarlato,	2017).	Besides,	 in	H.	pylori,	 it	was	demonstrated	 that	 HrcA	 is	 also	 an	 intrinsic	 heat-sensing	 protein.	 Indeed,	 this	protein	showed	thermal	stress	high	sensitive	structure,	which	allows	the	activity	of	the	 folded	 repressor	 only	 under	 heat-shock	 temperature	 (Roncarati,	 Danielli,	 &	Scarlato,	 2014).	 Interestingly,	 in	Rhodobacter	 capsulatus,	 it	 was	 observed	 that	 the	CIRCE	element	could	also	exert	an	extra	function,	affecting	transcript	stability	at	low	temperature,	 through	 the	 formation	 of	 a	 secondary	 structure	 promoted	 by	 the	inverted	 repeat	 (Jäger,	 Jäger,	 &	 Klug,	 2004).	 Although	 HrcA	 is	 found	 in	 various	bacteria,	 the	 sequence	 similarity	 among	 proteins	 from	 different	 species	 is	 low,	generally	 less	 than	 30%.	 However,	 the	 degree	 of	 similarity	 increases	 in	 highly	related	 microorganisms.	 Interestingly,	 the	 similarity	 is	 restricted	 to	 three	 short	amino	 acid	 regions,	 likely	 suggesting	 their	 essential	 role	 to	 the	 repressor	 activity	(Morimoto,	 1998).	 The	 high	 HrcA	 instability	 compromised	 its	 structural	determination;	 therefore,	 limited	 information	 is	 available	 nowadays.	 The	 only	protein	 architecture	 characterized	 comes	 from	 the	 Thermatoga	 maritima	 HrcA	crystal	 structure.	 Unfortunately,	 T.	 maritima	 expresses	 an	 inactive	 form	 of	 this	protein,	unable	to	bind	to	the	DNA.	However,	this	structure	reveals	a	dimeric	form,	where	 each	 monomer	 is	 composed	 of	 a	 helix-turn-helix	 (HTH)	 N-terminal	 DNA-binding	domains	(DBD),	a	central	domain	probably	involved	in	dimerization,	and	a	
	 17	
C-terminal	inserted	dimerizing	domain	(Liu	et	al.,	2005).			
1.2.1.2	HspR		HspR	is	a	transcriptional	repressor	showing	amino	acid	similarities	to	members	of	the	 MerR	 family	 of	 protein	 regulators.	 HspR	 was	 first	 identified	 in	 Streptomyces	
coelicolor,	 where	 it	 was	 demonstrated	 its	 ability	 to	 bind	 three	 inverted	 repeats,	named	HAIR	from	HspR	associated	inverted	repeats	(Bucca,	Hindle,	&	Smith,	1997)	(Bucca	et	al.,	1997).	 	Then,	 the	HspR-HAIR	system	was	 found	and	characterized	 in	diverse	 bacterial	 species.	 In	 several	 cases,	 the	 HAIR	 sequences	were	 identified	 in	proximity	 to	 the	 core	 promoter	 region	 (Grandvalet,	 De	 Crécy-Lagard,	&	Mazodier,	1999)	(Stewart	et	al.,	2002),	a	position	compatible	with	a	mechanism	of	repression	exerted	by	a	steric	hindrance	of	the	RNA	polymerase	to	the	promoter	region	(Spohn	et	 al.,	 2004)	 (A.	 Schmidt	 et	 al.,	 1992).	 In	H.	pylori,	HspR	represses	 transcription	of	some	 promoters	 in	 conjunction	 with	 the	 HrcA	 repressor	 (Roncarati	 &	 Scarlato,	2017).	Surprisingly,	on	these	promoters	the	HAIR	sequences	are	located	upstream	of	the	 transcriptional	 machinery	 binding	 site.	 This	 peculiarity	 suggests	 a	 different	repressing	strategy	in	the	HspR/HrcA	co-regulated	promoters,	if	compared	with	the	HspR	 only	 regulated	 ones	 (Roncarati	 &	 Scarlato,	 2017).	 Specifically,	 HspR	interactions	occur	 far	 upstream	of	 the	 core	promoter	 elements	 on	HspR/HrcA	 co-regulated	 promoters,	 while	 -35/-10	 boxes	 are	 obstructed	 by	 HrcA	 binding	(Roncarati,	 Danielli,	 et	 al.,	 2007).	 	 Another	 HspR	 feature	 is	 its	 high	 propensity	 to	oligomerize,	 which	 results	 in	 extended	 DNA-binding	 regions	 (Spohn	 et	 al.,	 2004).	The	 elaborate	 arrangement	 of	 the	 binding	 sites	 identified	 on	 the	 co-regulated	promoters,	 in	 addition	 to	 the	 HspR	 high	 oligomerization	 tendency,	 suggests	 a	complex	 DNA	 binding	 architecture	 able	 to	 finely	 regulate	 heat	 shock	 gene	expression	(Spohn	et	al.,	2004).	The	mechanism	by	which	HspR	can	respond	to	heat-shock,	 and	decrease	 its	DNA	binding	activity	 is	not	 completely	explained.	Also,	 for	this	 heat-shock	 repressor	 it	 is	 postulated	 a	 homeostatic	 control	 by	 chaperones	(Roncarati	 &	 Scarlato,	 2017),	 as	 confirmed	 by	 the	DnaK	 ability	 to	 stimulate	HspR	DNA	binding	in	S.	coelicolor	and	in	M.	tuberculosis	(Bucca,	Brassington,	Schönfeld,	&	Smith,	 2000)	 (Parijat	 &	 Batra,	 2015),	 and	 by	 the	 GroE	 involvement	 in	 the	 HspR	activation	 in	 M.	 tuberculosis	 (Das	 Gupta,	 Bandyopadhyay,	 &	 Das	 Gupta,	 2008).	
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Oppositely,	 in	H.	pylori	the	heat	shock	protein	CbpA	shows	a	negative	effect	on	the	HspR	repressor	activity.	Intriguingly,	this	function	occurs	only	when	the	repressor	is	not	 bound	 to	 the	 DNA	 target,	 revealing	 a	 fine	 regulatory	 mechanism	 to	 limit	 the	heat-shock	response	(Roncarati,	Danielli,	&	Scarlato,	2011).																													
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Aim	of	the	project		The	heat-shock	response	is	a	mechanism	of	cellular	protection,	which	bacteria	adopt	to	face	the	stress	conditions	able	to	compromise	the	protein	folding.	This	response	results	 in	 a	 fast	 expression	 of	 heat-shock	 genes	 with	 the	 consequent	 increase	 in	chaperones	 and	 proteases	 amount.	 The	 characteristic	 of	 being	 involved	 in	 the	preservation	 of	 the	 intracellular	 environment	 makes	 the	 heat-shock	 regulatory	circuit	 a	 crucial	 pathway	 during	 the	 establishment	 of	 host-pathogen	 interactions	when	the	microorganism	is	subject	to	different	stress	damages.	Moreover,	there	are	indications	that	heat-shock	proteins	may	play	a	role	in	host-specific	infection	in	the	food-borne	 pathogen	 C.	 jejuni.	 Besides,	 the	 heat-shock	 circuit	 ability	 to	 sense	temperature	changes	makes	this	response	a	potential	mechanism	by	which	C.	jejuni	can	 switch	 between	 commensalism	 in	 the	 chicken	 reservoir	 and	 pathogenicity	 in	humans.	Although	the	heat-shock	circuit	is	investigated	in	different	bacteria	species,	the	 molecular	 characterization	 of	 this	 response	 is	 not	 available	 for	 C.	 jejuni.	 The	purpose	of	this	work	is	to	elucidate	the	transcriptional	regulatory	modality	by	which	the	 pathogen	 can	 fine	 regulate	 chaperons	 and	proteases	 expression,	 clarifying	 the	molecular	mechanisms	on	the	roots	of	this	central	response.	With	this	purpose	and	starting	to	the	 involvement	of	 the	heat-shock	two	transcriptional	repressors,	HspR	and	 HrcA,	 in	 the	 regulatory	 circuit	 of	 C.	 jejuni,	 their	 interactions	 with	 potential	operators	 are	 investigated	 in	 detail	 by	DNase	 I	 footprinting	 assays.	Moreover,	 the	HspR	 complex	 DNA-binding	 architecture	 is	 elucidated,	 analyzing	 the	 regulator	interacting	 ability	 with	 several	mutants	 of	 the	 promoter	 sequences.	 Furthermore,	the	 HspR/HrcA	 co-regulation	 is	 explored	 on	 the	 common	 target	 by	 DNA	 in	 vitro	binding	 assays	 under	 competitive	 conditions.	Different	 protein-protein	 interaction	assays	are	also	performed	to	clarify	the	homo-	and	hetero-oligomerization	ability	of	the	two	repressors	involved	in	the	regulatory	circuit.	
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Results		
	
3.1	Investigation	of	the	CjHspR	heat-shock	
promoters	target	interaction			Previous	studies	 identified	 the	C.	jejuni	HspR	regulon	with	a	microarray	approach,	comparing	transcript	levels	of	wild	type	and	a	ΔhspR	mutant	strain	(Andersen	et	al.,	2005)	(Holmes	et	al.,	2010).	The	analysis	highlighted	thirty	deregulated	transcripts,	seventeen	 of	 which	 appeared	 downregulated,	 and	 thirteen	 were	 upregulated.	 A	further	bioinformatics	analysis	was	applied	to	 identify	putative	HspR	binding	sites	in	 proximity	 of	 deregulated	 promoters.	 Sequences	 with	 similarities	 to	 the	 HAIR-sequence	 motif	 from	 Streptomyces	 ssp	 were	 identified	 in	 four	 promoter	 regions,	inferring	the	operons	carrying	these	motifs	as	putative	direct	 targets	of	HspR	in	C.	
jejuni.	Figure	3	shows	a	schematic	representation	of	these	operons,	consisting	of	the	
Pcbp,	 Pclp,	 Pgro,	 and	 Phrc	 promoters,	 which	 control	 transcription	 of	 the	 major	chaperone	 and	 hrcA	 and	 hspR	 regulatory	 genes.	 The	 scheme	 also	 displays	 the	positions	of	the	HAIR-like	motif	in	the	promoter	regions.	However,	the	functionality	of	 HAIR-like	 sequences	 is	 not	 supported	 by	 experimental	 evidence,	 and	 a	mechanism	 able	 to	 explain	 the	 HspR	 transcriptional	 repression	 effect	 is	 not	identified	(Andersen	et	al.,	2005)	(Holmes	et	al.,	2010).							
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Figure	 3:	Schematic	representation	of	 the	chaperone	genes	 in	C.	jejuni.	Open	arrows	indicate	coding	genes.	HAIR-like	motifs	are	represented	by	convergent	arrows.	Bent	arrowed	indicate	the	start	sites	of	transcription	at	the	indicated	promoters.		To	 start	 the	 characterization	 of	CjHspR	 binding	 on	 these	 regions,	 and	 explore	 the	role	of	 the	 identified	HAIR-like	sequences	 in	 repressor	binding,	we	set	up	DNase	 I	footprinting	 assays	with	purified	 recombinant	CjHspR	on	 the	Pcbp,	Pclp,	Pgro,	and	
Phrc	 promoter	 probes.	 Initiation	 of	 RNA	 transcription	 on	 these	 promoters	 was	identified	 by	 RNA-sequencing	with	 a	 SuperGenome	 approach	 (Dugar	 et	 al.,	 2013)	and	verified	in	this	study	by	primer	extension	analyses	(data	not	shown).		
3.1.1	CjHspR	interacts	with	multiple	sites	of	the	heat-shock	
promoters		To	demonstrate	 the	direct	 interaction	of	CjHspR	to	 the	potential	 target	promoters,	increasing	 concentrations	 of	 purified	 recombinant	 CjHspR	 were	 incubated	 with	radiolabeled	DNA	probes	spanning	the	Pcbp,	Pclp,	Pgro,	and	Phrc	promoter	regions	and	then	digested	with	DNase	I	and	fractionated	on	polyacrylamide	denaturing	gel.	The	result	(fig.	4)	is	consistent	with	a	DNase	I	footprinting	assays	obtained	when	the	binding	 of	 a	 protein	 on	 the	DNA	probe	 occurs.	Data	 reported	 in	 the	 figure	 clearly	shows	that	upon	increase	of	the	amount	of	CjHspR	in	the	reaction,	area	of	DNase	I	protection	are	detected,	due	to	the	binding	of	the	protein	that	precludes	DNase	I	cut.	In	 addition,	 binding	 of	 the	 protein	 give	 rise	 to	 the	 appearence	 of	 bands	 of	
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hypersensitivity	to	DNase	I,	likely	an	effect	of	structural	DNA	changes	determined	by	the	binding	of	the	protein.	
	
	
	
Figure	 4:	 High	 resolution	 mapping	 of	 CjHspR	 binding	 sites	 on	 heat-shock	promoters.	DNase	I	footprinting	assays	of	CjHspR	on	Pcbp,	Pclp,	Pgro	and	Phrc	promoter	 probes	 (panels	 A,	 B,	 C	 and	 D,	 respectively).	 Radiolabelled	 DNA	probes	 were	 incubated	 with	 increasing	 concentrations	 of	 the	 HspR	recombinant	 protein	 (0,	 11,	 22,	 45,	 90	 and	 180	 nM	 CjHspR;	 lanes	 1	 to	 6,	respectively)	at	room	temperature	and	subjected	to	limited	DNase	I	digestion.	In	 each	 panel,	 on	 the	 right	 the	 grey	 boxes	 highlight	 regions	 of	 DNase	 I	protection	 and	 the	 black	 arrowheads	 indicate	 bands	 of	 hypersensitivity	 to	DNase	 I	 digestion;	while	 on	 the	 left,	 bent	 arrows	 indicate	 the	 transcriptional	start	 site	and	vertical	open	arrows	depict	 the	open	 reading	 frames;	numbers	refer	to	the	positions	with	respect	to	the	transcriptional	start	sites.			The	 experiment	 carried	 out	 on	 the	 Pcbp	 promoter	 probe	 shows	 protection	 from	DNase	 I	 digestion	 between	 the	 position	 -50	 and	 the	 -20	 above	 the	 transcriptional	start	site	(Panel	A,	lanes	3-6).	Also,	two	bands	of	hypersensitive	DNase	I	sites	appear	in	proximity	of	position	 -50	 (lane	3).	Upon	addition	of	 increasing	concentration	of	
CjHspR	 in	 the	 reaction,	 a	 second	 area	 of	 protection	 and	 two	 additional	hypersensitive	 bands	 close	 to	 position	 -65	 (lanes	 4-6)	 were	 detected.	 A	 similar	result	was	 obtained	 on	 the	Pclp	 promoter	 probe	 (panel	B),	where	 the	 experiment	
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displayed	 a	 protected	 region	 with	 flanking	 hypersensitive	 bands	 (lanes	 3).	Moreover,	an	area	of	protection	emerges	at	high	CjHspR	concentration	(lanes	4-6),	and	three	hypersensitive	bands	is	detected,	two	of	which	in	the	proximity	of	position	+1.	 Besides,	 a	 protection	 region	 and	hypersensitive	 bands	 are	 visible	 upstream	 to	the	 -50	 position.	 The	 DNase	 I	 footprinting	 assay	 on	 the	 Pgro	 (panel	 C),	 instead,	shows	two	bands	of	DNase	I	hypersensitivity	mapping	to	the	position	-50	and	the	-80	at	lower	repressor	concentration	(lane	3-6),	and	two	protected	regions	between	the	 -50	 and	 -110	 at	 higher	 CjHspR	 concentration	 (lanes	 4-6).	 Finally,	 additional	hypersensitive	 bands	 close	 to	 the	 position	 -40	 (lanes	 4-6)	 with	 an	 adjacent	protection	 region	 (lanes	 5-6)	 appear.	 On	 the	 Phrc	 promoter	 probe	 (panel	 D),	hypersensitivity	 bands	 are	 identified	 close	 to	 the	 position	 -90	 at	 low	 repressor	concentration	(lanes	3-6)	with	a	protection	region	between	the	position	-90	and	the	-55	(lanes	4-6).	Increasing	CjHspR	concentration,	two	hypersensitivity	bands	appear	between	 the	 position	 -100	 and	 the	 -110	 (lanes	 4-6)	 with	 a	 protection	 region	 in	proximity	to	the	position	-110.	Moreover,	an	additional	band	tightly	the	-50	(lanes	3-6)	and	a	protection	region	near	the	-30	is	exhibited	at	higher	protein	concentration	(lane	 6).	 Of	 note,	 the	 protection	 pattern	 of	 CjHspR	 on	 the	 DNA	 probes	 show	 an	interacting	 region	 already	 at	 lower	 protein	 concentration	with	 additional	 binding	areas	 detectable	 at	 higher	 protein	 concentration,	 suggesting	 the	 presence	 of	 high	and	 low-affinity	binding	sites.	 In	summary,	 low-	and	high-affinity	binding	sites	are	identified	on	the	Pcbp	and	Pclp.	Differently,	a	central	high-affinity	binding	site	with	two	 flanking	 low-affinity	 sites	 are	detected	 on	 the	Pgro	promoter.	 In	 contrast,	 the	
Phrc	reveal	a	central	high-affinity	site	with	a	closely	low-affinity	binding-site	and	a	potential	very	low-affinity	site.		
3.1.2	Analysis	of	the	HAIR-like	motif	sequence	in	C.	jejuni		The	 HAIR	 motif	 proposed	 as	 a	 consensus	 sequence	 for	 the	 HspR	 protein	 of	 S.	
coelicolor	is	constituted	by	IR	spanning	21	bp	(CTTGAGT-N7-ACTCAAG)	(Grandvalet	et	 al.,	 1999).	 Inspection	 of	 the	 DNA	 regions	 interacting	with	 CjHspR	 revealed	 the	presence	of	 five	HAIR-like	 sequences	 in	addition	 to	 the	previously	 reported	HAIR-like	 sequences	 (Andersen	et	al.,	2005)	 (Holmes	et	al.,	2010)	 (fig.	 3).	Of	 these,	 two	HAIRs	map	 in	the	Pcbp	and	Pclp	promoter	regions	and	three	HAIRs	are	 located	on	
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Pgro	and	Phrc	 promoters.	 The	 nucleotide	 sequences	 of	 the	 four	 promoters	 (Pcbp,	
Pclp,	Pgro,	and	Phrc)	and	their	key	regulatory	elements	are	summarized	in	figure	5.	Strikingly,	while	 the	HAIR-like	 sequences	 span	 over	 the	Pcbp,	Pclp,	 and	Phrc	 core	promoter	 elements	 (-10	 and	 -35	boxes),	 no	HAIR-like	 sequences	 overlap	 the	Pgro	promoter	 region,	 mapping	 upstream	 of	 the	 -35	 region.	 This	 distinct	 binding	architecture	on	the	promoter	regions	suggests	diversified	mechanisms	of	repression	exerted	by	CjHspR.			
	
Figure	 5:	Features	of	 the	Pcbp,	Pclp,	Pgro	and	Phrc	promoter	sequences.	For	each	 is	 indicated	 the	 promoter	 sequence,	 and	 numbers	 are	 referred	 to	 the	transcriptional	start	site	(+1).	The	-10	and	35	boxes	are	underlined	bold	on	the	coding	DNA	strand.	The	HAIR-like	sequences	are	represented	in	boldface.	The	HAIR-like	 sequences	 identified	 in	 this	 study	are	 grey	highlight.	 	 The	DNase	 I	protection	 regions	 are	 highlight	 with	 boxes	 with	 different	 size,	 where	 the	height	is	indication	of	HspR	binding	affinity	for	the	specific	region.		To	 gain	 insight	 on	 the	 role	 of	 the	 HAIR-like	 motif	 and	 identify	 key	 conserved	nucleotides	 for	 CjHspR	 binding,	 HAIR	 sequences	 were	 aligned	 and	 submitted	 to	WebLogo	 computer	 program	 with	 results	 shown	 in	 fig.	 6.	 Alignment	 of	 all	 HAIR	sequences	highlighted	nucleotides	conservation	within	an	imperfect	IR	of	21	bp.	The	most	conserved	nucleotides	are	the	 first	 three	of	 the	 left	emisite,	CTT.	 Instead,	 the	right	emisite	appears	less	conserved,	and	the	higher	conserved	nucleotides	are	one	
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T	 and	 one	 A,	 which	 are,	 however,	 rather	 widespread	 as	 compared	 o	 the	 three	nucleotides	 conserved	 in	 the	 left	 emisite	 (panel	 A).	 Restricting	 the	 analysis	 to	 the	HAIR	sequences	found	in	high-affinity	CjHspR	binding	sites,	the	dissimilarity	of	the	two	 portions	 of	 the	 inverted	 repeat	 decreases	 (panel	 B),	 suggesting	 that	 the	differences	 between	 the	 high-	 and	 low-affinity	 HAIR	 may	 reside	 in	 the	 right	 IR	emisite	conservation.	
	
A																																																														B
			
Figure	6:	:	WebLogo	representations	of	the	HAIR	sequences	characterized	through	DNase	I	footprinting	assays,	A:	all	identified	HAIR	sequences,	B:	HAIR	sequences	of	high	affinity	binding	sites.	
	
3.1.3	Elucidation	of	the	repressor	binding	architecture	and	
the	binding-site	hierarchy		The	 above	 study	on	CjHspR-DNA	 interaction	 revealed	 an	 intriguing	 scenario	based	on	multiple	 binding	 elements	 associated	 with	 each	 promoter	 and	 showing	 a	 variable	propensity	to	interact	with	the	repressor.	The	HAIR	sequence	analysis	suggests	that	the	diversity	 in	protein	interaction	ability	might	reside	in	the	different	conservation	of	the	two	 emisites.	 To	 investigate	 the	 relevance	 of	 the	 two	 portions	 of	 the	 HAIR	motif,	 we	generated	 mutants	 of	 one	 or	 both	 emisites,	 and	 assayed	 their	 interacting	 ability	 to	
CjHspR	by	DNase	I	 footprinting	experiments	(fig.	 7).	Specifically,	we	selected	the	Pcbp	and	 Pgro	 promoters	 for	 the	 analysis,	 as	 representatives	 of	 two	 different	 binding	architectures	for	CjHspR.	Pcbp	shows	a	promoter-proximal	high-affinity	binding	site	and	an	 upstream	 low-affinity	 site.	 At	 the	 same	 time,	 Pgro	 carries	 a	 central	 high-affinity	binding	site	flanked	by	two	low-affinity	sites,	all	upstream	of	the	core	promoter	region.		Base	 substitutions	 were	 applied	 to	 the	 high-affinity	 binding	 sites	 by	 changing	 each	
	 26	
base/position	 and	 maintaining	 the	 same	 base	 composition.	 A	 representation	 of	 the	constructed	mutants	is	depicted	in	figure	7	(1).		
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Figure	7:	Features	of	the	Pclp	and	Pgro	wild	type	or	mutants	promoter	sequences	(panel	1).	For	each	are	indicated	promoter	sequence,	and	numbers	are	referred	to	the	 transcriptional	 start	 site	 (+1).	 The	 HAIR-like	 sequences	 are	 represented	 in	boldface,	 and	 the	 mutated	 sequences	 are	 grey	 highlight.	 DNase	 I	 footprinting	assays	of	CjHspR	on	wild	type	Pcbp	(panel	A)	or	on	mutants	MHL	(panel	B),	MHR	(panel	C)	and	MH	(panel	D)	probes	(pannel2),	and	on	wild	type	Pgro	(panel	A)	or	on	mutants	MHL	 (panel	 B),	MHR	 (panel	 C)	 and	MH	 (panel	 D)	 probes	 (panel	 3).	Radiolabelled	 DNA	 probes	 were	 incubated	 with	 increasing	 concentrations	 of	recombinant	CjHspR	protein	(0,	22,	45,	90,	180,	360	and	720	nM	CjHspR;	lanes	1	to	7)	at	room	temperature	and	subjected	to	partial	DNase	I	digestion.	On	the	right	of	each	 panel,	 grey	 boxes	 depict	 the	 regions	 of	 DNase	 I	 protection	 and	 black	arrowheads	 indicate	 bands	 of	 hypersensitivity	 to	 DNase	 I	 digestion.	 On	 the	 left,	schematic	representation	of	the	promoter	region,	where	the	bent	arrows	indicate	the	transcriptional	start	site,	vertical	open	arrows	depict	the	open	reading	frame;	numbers	refer	to	the	positions	with	respect	to	the	transcriptional	start	sites.	Grey	boxes	 represent	 the	wild	 type	HAIR	sequences,	while	empty	boxes	represent	 the	mutated	sequences.			Comparing	 the	 DNase	 I	 footprinting	 assays	 results	 of	 CjHspR	 on	 Pcbp	 (2)	 wild	 type	(panel	A)	 to	mutant	probes	 (panels	B,	C,	D),	 it	 emerged	 that	mutation	on	one	or	both	portions	of	 the	HAIR	elicits	 loss	of	CjHspR	protection.	A	partial	 loss	of	HspR	affinity	 is	visible	in	the	mutant	of	the	less	conserved	“right”	emisite	of	the	HAIR	(probe	MHR,	panel	B).	Differently,	the	mutation	of	the	more	conserved	“left”	emisite	(probe	MHL,	panel	C)	produces	a	more	severe	 loss	 in	protein	affinity,	which	 is	reflected	 in	a	 light	protection	region	 with	 three	 hypersensitive	 bands,	 and	 detectable	 only	 with	 higher	 HspR	concentration.	 This	 result	 highlights	 a	 possible	 key	 role	 of	 the	 more	 conserved	 left	emisite	in	the	recruitment	of	the	repressor	on	the	Pcbp.	Finally,	mutations	of	both	HAIRs	emisites	(probe	MH,	panel	D)	abolish	almost	totally	the	CjHspR	binding	to	the	site	and	allow	 the	 appearance	 of	 one	 residual	 hypersensitive	 band	 at	 extremely	 high	 HspR	concentration.	 An	 analogous	 result	 was	 obtained	 on	 the	 Pgro	 promoter	 probe	 (3),	where,	however,	 the	mutation	on	one	of	 the	 two	HAIR	portions	elicits	a	more	gradual	loss	of	CjHspR	protection,	 if	compared	with	the	same	mutation	 in	Pcbp	promoter.	This	allows	 appreciating	 the	 distinct	 effect	 generated	 by	 the	 specific	mutations,	 harsher	 in	the	case	of	mutation	on	the	more	conserved	“right”	emisite	(MHR,	panel	B)	than	in	the	“left”	emisite	(MHL).	The	consequences	of	mutations	on	one	of	the	two	emisites	appear	to	be	less	strict	on	Pgro	promoters	then	on	Pcbp,	presumably	because	of	the	presence	of	two	low-affinity	HAIR	sites	flanking	the	one	mutated	in	the	Pgro.	Complete	disruption	of	the	high-affinity	HAIR	(MH,	panel	D)	determined	total	loss	of	CjHspR	protection	pattern.	
	 29	
These	 results	demonstrate	 that	CjHspR	binging	 to	DNA	requires	a	 full	HAIR	motif	 and	that	mutations	on	 the	high-affinity	HAIR	 also	determine	 a	 severe	 reduction	of	CjHspR	interaction	 with	 the	 low-affinity	 binding	 site.	 Nevertheless,	 these	 results	 are	 not	sufficient	to	explain	the	role	exerted	by	the	additional	HAIRs	on	the	promoters.		To	grasp	information	on	the	function	of	multiple	CjHspR	binding	sites	on	regulated	promoters,	we	performed	 DNase	 I	 footprinting	 experiments	 on	 the	 Pgro	 promoter	 mutated	 in	 each	HAIR	motif	(fig.	8).	
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Figure	8:	Features	of	Pgro	wild	type	or	mutants	promoter	sequences	(panel	1).	For	each	is	 indicated	promoter	sequence,	numbers	are	referred	to	the	transcriptional	start	 site	 (+1).	 The	 HAIR-like	 sequences	 are	 represented	 in	 boldface,	 and	 the	mutated	 sequences	 are	 grey	 highlight	 (1).	 And	 DNase	 I	 footprinting	 assays	 of	
CjHspR	on	wild	type	Pgro	or	mutants	MH	(panel	B),	MM	(panel	C)	and	ML	(panel	D)	 probes	 (panel	 2).	 Radiolabelled	 DNA	 probes	 were	 incubated	 with	 different	concentrations	of	recombinant	CjHspR	protein	(0,	22,	45,	90,	180,	360	and	720	nM	HspR;	lanes	1	to	7)	at	room	temperature	and	subjected	to	partial	DNase	I	digestion.	On	the	right	of	each	panel,	grey	boxes	depict	the	regions	of	DNase	I	protection	and	black	arrowheads	 indicate	bands	of	hypersensitivity	 to	DNase	 I	digestion.	On	 the	left,	 schematic	 representation	 of	 the	 promoter	 region,	 where	 the	 bent	 arrows	indicate	the	transcriptional	start	site,	vertical	open	arrows	depict	the	open	reading	frame;	numbers	refer	to	the	positions	with	respect	to	the	transcriptional	start	sites.	Grey	boxes	represent	the	wild	type	HAIR	sequences,	while	white	boxes	represent	the	mutated	sequences.		The	DNase	I	footprinting	experiment	results	displays	how	disruption	of	the	central	high-affinity	HAIR	(MH,	panel	B)	determined	a	drastic	loss	of	the	DNase	I	protection	pattern	by	CjHspR.	This	evidence	highlighted	the	essential	role	of	the	central	high-affinity	HAIR	for	the	recruitment	of	the	transcriptional	repressor	on	the	promoter.	In	contrast,	DNase	I	 footprinting	 assays	 on	 promoter	 probes	 carrying	 mutations	 in	 the	 two	 low-affinity	HAIR	motifs	(MM,	panel	C	and	ML,	panel	D)	exhibited	a	drastic	 loss	of	CjHspR	binding	
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affinity	 exclusively	 for	 the	mutated	 sequences,	without	 altering	 the	protection	pattern	on	the	remaining	unaltered	binding	sites	(C	and	D).	This	finding	reveals	that	the	flanking	low-affinity	 HAIR	 motifs	 are	 not	 necessary	 for	 CjHspR	 interaction	 with	 high-affinity	HAIR	sequences.	Moreover,	the	observation	that	a	high-affinity	HAIR	site	is	required	for	the	 repressor	 recruitment	 on	 the	 promoter	 highlights	 the	 fundamental	 role	 that	 the	high-affinity	HAIR-CjHspR	 interaction	has	 to	enhance	 the	repressor	binding	with	close	low-affinity	site.	Moreover,	these	results	underline	a	binding	hierarchy	among	the	HAIRs	located	 in	a	single	promoter	and	depending	not	only	on	 IR	sequence	conservation	but	also	on	the	binding	sites	reciprocal	position.	This	evidence	suggests	a	potential	role	for	the	 CjHspR-CjHspR	 intermolecular	 connections	 that	 might	 occur	 between	 repressors	closely	 bound	 on	 the	 same	 promoter,	 and	 aimed	 to	 stabilize	 the	 repressor-promoter	interaction.				
3.2	Characterization	of	the	CjHrcA	binding	on	heat-
shock	promoters			In	the	same	studies	mentioned	above,	a	microarray	approach,	was	carried	out	to	define	the	C.	jejuni	HrcA	regulon.	This	whole	transcriptomic	approach	was	combined	with	an	in	
silico	search	of	putative	CjHrcA	binding	sites	 looking	for	sequences	with	similarities	to	the	 CIRCE-sequence	motif	 from	B.	 subtilis	 in	 the	 proximity	 of	 deregulated	 promoters.	Specifically,	the	C.	jejuni	NCTC	11168	genome	was	analysed	for	the	presence	of	CIRCE-like	 elements	using	 fuzznuc	program	 from	EMBOSS	 (“the	European	Molecular	Biology	Open	Software	Suite”),	leading	to	the	identification	of	only	one	putative	CjHrcA	operator	located	in	the	Pgro	promoter	region	(Holmes	et	al.,	2010).	It	is	worth	mentioning	that	an	additional	CIRCE	element	situated	 in	the	Phrc	promoter	has	been	previously	proposed	(Thies,	Karch,	Hartung,	&	Giegerich,	1999).	Figure	9	reports	a	schematic	representation	of	the	two	potential	target	operons	mentioned	above.	Starting	from	this	information,	we	focussed	our	efforts	on	the	study	of	CjHrcA-DNA	binding	ability	on	both	the	promoters,	through	in	vitro	DNA-binding	assays.			
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Figure	9:	hrc	and	gro	operons’	schematic	representation,	the	two	potential	CIRCE	sequences	are	indicated	on	the	promoters	regions.	Symbols	are	as	in	the	legend	to	fig.	3.		
3.2.1	CjHrcA	specifically	binds	to	Pgro	and	Phrc	promoters		To	 investigate	CjHrcA	direct	 interaction	with	previously	proposed	CIRCE	elements,	we	used	the	Pgro	and	the	Phrc	promoter	regions	as	a	probe	for	in	vitro	binding	to	a	purified	
CjHrcA	 protein	 in	DNase	 I	 footprinting	 assays.	Figure	 10	 shows	 the	CjHrcA	 ability	 to	bind	and	protect	defined	portions	of	the	two	probes.	The	protected	regions	overlap	with	the	potential	CIRCE	elements	on	both	promoters.	More	in	detail,	the	DNase	I	footprinting	experiment	on	Pgro	 (Figure	 10;	 panel	 1,	 A)	shows	three	bands	of	hypersensitivity	 to	DNase	I	digestion,	which	appear	starting	from	lanes	2	and	3,	and	two	DNase	I	protection	regions	 noticeable	 from	 lane	 4	 and	 overlapping	 the	 transcriptional	 start	 site	 (+1	position).	Figure	10;	panel	1,	B	shows	that	upon	the	addition	of	CjHrcA	to	the	labeled	
Phrc	 probe,	 a	 clear	 region	 of	 protection	 appears,	 flanked	 on	 one	 side	 by	 a	 DNAse	 I	hypersensitive	 band.	 Also,	 in	 this	 case,	 the	 CjHrcA	 protected	 region	 encloses	 the	transcriptional	start	site.	We	conclude	that	CjHrcA	binds	to	the	Pgro	and	Phrc	promoters	by	contacting	DNA	regions	overlapping	the	transcription	start	sites,	and	encompassing	the	previously	proposed	CIRCE	elements.				
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Pcbp	
 
  
  -80       -70       -60       -50       -40       -30       -20      -10       +1        +10       +20        +30  
AAAATTGTAAATAAAACCTTGAGTGATAAAAATTTATAAAACTTGATTGACTTAGGCTAAAGTTTATGTTATAATTTAATCCTCTATATAATCAAGTAAAAATTTTTAAGGAAATATAACAT 
TTTTAACATTTATTTTGGAACTCACTATTTTTAAATATTTTGAACTAACTGAATCCGATTTCAAATACAATATTAAATTAGGAGATATATTAGTTCATTTTTAAAAATTCCTTTATATTGTA 
 
 
 
 
 
 
Pclp	
 
 
       -100      -90       -80       -70       -60       -50        -40       -30       -20       -10       +1        +10  
TCTAAAATTAGTCATTTGTCCTATTATTTAAAAAATTTTACTCAATTAACTTGACATTATATGACTAAAGTTATATAATAGCAAGTCTATAAACTAAATAAAGGATAAAACATGGCAAATA 
AGATTTTAATCAGTAAACAGGATAATAAATTTTTTAAAATGAGTTAATTGAACTGTAATATACTGATTTCAATATATTATCGTTCAGATATTTGATTTATTTCCTATTTTGTACCGTTTAT 
 
 
 
 
 
Pgro	
 
 
 
  -110      -100      -90       -80       -70       -60       -50       -40       -30       -20       -10       +1 
TTTTATCCTTTAGTTTATTTTATAAAATAACTTTAGTCTATAAAACTAAACTTTTATAAATATTTTAATTTAAAGTATTGACAAAATTCATTTTTTATAGTATGATATTATCACTCTAAAT 
AAAATAGGAAATCAAATAAAATATTTTATTGAAATCAGATATTTTGATTTGAAAATATTTATAAAATTAAATTTCATAACTGTTTTAAGTAAAAAATATCATACTATAATAGTGAGATTTA 
 
 			
Phrc			
 
        -110      -100      -90       -80       -70       -60       -50       -40       -30       -20       -10       +1  
GCTTATCCTTATAAAAAAGTAACTAATAAAACTTTAGTCATATTGACTAAATAAAATTAAGTATATTTTTTTATATTTATACTTGACAAAATAACACTCAATGTTGTATAATATATCTAG 
CGAATAGGAATATTTTTTCATTGATTATTTTGAAATCAGTATAACTGATTTATTTTAATTCATATAAAAAAATATAAATATGAACTGTTTTATTGTGAGTTACAACATATTATATAGATC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pgro	
 
 
  -40       -30       -20  ∨   -10       +1     ∨  +10       +20    ∨ 
AAGTATTGACAAAATTCATTTTTTATAGTATGATATTATCACTCTAAATTAAAGAGTGCTAAAATCAATATTTTTAA 
TTCATAACTGTTTTAAGTAAAAAATATCATACTATAATAGTGAGATTTAATTTCTCACGATTTTAGTTATAAAAATT 
 
 
Phrc	
 
 
-40       -30       -20       -10∨     +1        +10       +20 
TACTTGACAAAATAACACTCAATGTTGTATAATATATCTAGCAATCAAAAAATAGAGTGCTAGATATGAAGGAAAAT 
ATGAACTGTTTTATTGTGAGTTACAACATATTATATAGATCGTTAGTTTTTTATCTCACGATCTATACTTCCTTTTA 																						
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Figure	10:	panel	1.	High	resolution	mapping	of	CjHrcA	binding	sites	on	heat-shock	genes’	promoters.	DNase	I	footprinting	assays	of	CjHrcA	on	Pgro	and	Phrc	promoters.	Radiolabelled	 DNA	 probes	 were	 incubated	 with	 different	 concentrations	 of	recombinant	 CjHrcA	 protein	 (0,	 22,	 45,	 90,	 180	 and	 360	 nM	 CjHrcA;	 lanes	 1	 to	 6,	respectively)	at	room	temperature,	and	followed	by	partial	DNase	I	digestion.	In	each	panel,	 on	 the	 right	 the	 grey	 boxes	 highlight	 regions	 of	 DNase	 I	 protection	 and	 the	black	arrowheads	 indicate	bands	of	DNase	 I	hypersensitivity;	while	on	 the	 left	bent	arrows	indicate	the	transcriptional	start	site	and	vertical	open	arrows	depict	the	open	reading	 frames;	 numbers	 refer	 to	 the	 positions	 with	 respect	 to	 the	 transcriptional	start	 sites.	 Panel	 2.:	 Features	 of	 Pgro	 and	 Phrc	 promoter	 sequences.	 For	 each	 is	indicated	promoter	sequence,	and	numbers	are	 referred	 to	 the	 transcriptional	 start	site	 (+1).	 The	 -10	 and	 35	 boxes	 are	 underlined	 bold,	 and	 the	 CIRCE	 sequences	 are	represented	 in	 boldface.	 DNase	 I	 protection	 regions	 are	 grey	 highlight	 and	 the	hypersensitives	DNase	I	cut	are	indicated	with	black	tick.	
	
3.3	Characterization	of	the	CjHspR/CjHrcA	binding	on	
the	co-regulated	promoters		Following	DNase	 I	 footprinting	 assays	described	 above,	we	have	been	 able	 to	 identify	extended	 CjHspR	 binding	 sites	 on	Pgro	and	Phrc	 promoters	 located	 far	 upstream	 the	core	promoter	region,	in	an	atypical	position	for	a	transcriptional	repressor.	Moreover,	on	the	same	promoters,	we	demonstrated	the	presence	of	a	CjHrcA	binding	site	that	is,	instead,	 located	 within	 the	 core	 promoter	 overlapping	 the	 transcriptional	 start	 site.	Notably,	 the	 distances	 between	 the	CjHspR	 and	CjHrcA	 binding	 sites	 on	 the	Pgro	 and	
Phrc	promoters	are	32	and	14	bp,	suggesting	the	possibility	of	direct	interaction	and	a	functional	 interplay	between	 the	 two	regulators,	 and	potential	 cooperative	 interaction	of	the	two	repressors	on	these	common	targets.			
	
Figure	 11:	 hrc	 and	 gro	 operons’	 schematic	 representation,	 on	 the	 promoters	regions	the	regulatory	elements	are	indicated.	
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3.3.1	CjHspR	and	CjHrcA	mutual	cooperative	effect	on	DNA	
binding	to	specific	operators			To	 study	 possible	 interactions	 of	 CjHspR	 and	 CjHrcA,	 we	 assayed	 the	 DNA	 binding	activities	 of	 both	 proteins	 by	 carrying	 out	 DNase	 I	 footprinting	 experiments	 on	 Pgro	under	competitive	conditions	(fig.12).	Panel	A	shows	the	results	of	DNA-binding	assays	carried	out	using	CjHspR	in	combination	with	CjHrcA	(lanes	7	to	12)	or	with	a	control	protein	(GST,	lanes	1	to	6).	The	addition	of	increasing	amounts	of	CjHspR	after	binding	of	CjHrcA	to	the	labelled	probe	resulted	in	enhanced	footprinting	patterns	compared	to	those	obtained	by	incubating	CjHspR	without	CjHrcA.	This	effect	is	particularly	evident	by	 comparing	 the	 intensities	of	 all	 the	DNase	 I	 hypersensitive	bands,	which	appear	 at	lower	CjHspR	protein	concentration	in	the	presence	of	CjHrcA.	Similar	result	is	obtained	when	 increased	 concentrations	 of	 CjHrcA	 are	 added	 to	 CjHspR	 bound	 to	 the	 same	promoter	probe	(Figure	12,	panel	B).	Also	in	this	case,	the	CjHrcA	footprinting	pattern	is	enhanced	by	the	incubation	of	the	CjHrcA	protein	with	a	DNA	probe	binding	to	CjHspR	(lanes	7	to	12),	if	compared	to	the	control	set	(lanes	1	to	6).	Consequently,	we	concluded	that	 on	 Pgro	 co-regulated	 promoter	 and	 under	 the	 in	 vitro	 conditions	 used,	 the	 two	regulatory	proteins	display	a	mutual	cooperative	mechanism	of	DNA	binding.			
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Figure	12:	DNase	I	footprinting	assays	of	CjHspR	on	Pgro	(0,	22,	45,	90,	180	and	360	nM,	lanes	1	to	6	and	7	to	12;	panel	A)	with	GST	(360	nM,	lines	1	to	6)	or	CjHrcA	(360	nM,	lines	7	to	12)	and	CjHrcA	(0,	22,	45,	90,	180	and	360	nM,	lanes	1	to	6	and	7	to	12;	panel	B)	with	GST	(180	nM,	lines	1	to	6)	or	CjHspR	(360	nM,	lines	7	to	12).	In	each	panel,	on	the	right	grey	boxes	highlight	the	regions	of	DNase	I	protection	and	the	black	arrowheads	indicate	bands	of	hypersensitivity	to	DNase	I	digestion	of	CjHspR	or	CjHrcA,	panel	A	and	B	respectively.	On	the	left,	bent	arrows	indicate	the	transcriptional	start	site,	vertical	open	arrows	depict	the	open	reading	frame;	numbers	refer	to	the	positions	with	respect	 to	the	transcriptional	start	sites.	The	HAIR	and	CIRCE	sequences	are	indicated	by	dark	and	light	grey	boxes	respectively.							
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3.4	Investigation	of	the	CjHspR/CjHspR	and	
CjHspR/CjHrcA	interactions		The	DNA	binding	experiments	described	above	allowed	to	discover	a	complex	binding	architecture.	More	in	detail,	 the	role	played	by	the	high-affinity	HAIR	in	promoting	the	
CjHspR	binding	on	 the	 flanking	 low-affinity	site(s)	may	be	explained	by	an	 interaction	between	 functional	units	of	CjHspR,	 each	of	which	would	make	 contact	with	one	DNA	binding	site	but	also	with	the	flanking	CjHspR.	Moreover,	and	as	described	previously,	a	
CjHspR-CjHrcA	interaction	may	be	involved	in	the	mutual	cooperative	effect	of	the	two	repressors.	To	test	 this	hypothesis,	we	performed	different	protein-protein	 interaction	assays.		
3.4.1	CjHspR	and	CjHrcA	interaction		To	investigate	a	direct	CjHrcA-CjHspR	interaction,	we	performed	an	in	vitro	cross-linking	assay	with	the	two	overexpressed	and	purified	proteins		(fig.	13).				
Figure	 13:	 Cross-linking	 assay	 of	CjHspR+CjHrcA,	 CjHrcA+CjHrcA	 and	CjHspR+CjHspR	 incubated	 with	 or	without	 glutaraldehyde.	 R:	 CjHspR,	
A:	CjHrcA	and	X:	glutaraldehyde.							In	detail,	the	CjHspR	and	CjHrcA	proteins	were	incubated	separately	or	mixed	together	with	a	crosslinker	(glutaraldehyde)	and	fractionated	on	SDS-PAGE.	The	results	obtained	indicate	 that	 both	 proteins	 could	 form	 dimers	 in	 solution.	 The	 simples	 containing	
CjHspR	alone	 (Figure	 13,	 lanes	 labeled	RR	and	RR-X)	 exhibit	 a	 significant	 increase	of	one	 band	 with	 an	 apparent	 molecular	 mass	 of	 ca.	 30	 kDa,	 only	 after	 glutaraldehyde	treatment	(compare	lane	RR	with	RR-X).	The	band	observed	following	protein	cross-link	
MW			 AR-X		 AR		 AA-X		 AA							
				
RR-X			
		
RR							
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might	 represent	 a	 dimeric	 form	of	 the	CjHspR	protein,	 considering	 that	 the	molecular	weight	 of	 recombinant	CjHspR	 is	 15	kDa.	An	 analogous	observation	 is	 done	when	 the	crosslinker	 is	 added	 to	 the	 reaction	 containing	 CjHrcA	 alone.	 Even	 if	 in	 this	 case	 the	purity	of	the	protein	preparation	is	lower,	it	is	possible	to	observe	a	band	with	apparent	molecular	mass	of	ca.	62	kDa	upon	addition	of	glutaraldehyde	(Figure	13,	lane	labelled	AA-X),	likely	representing	a	dimer	of	CjHrcA	(CjHrcA	monomer	molecular	weight	slightly	exceed	 ca.	 30	KDa).	 Interestingly,	 the	 incubation	of	 glutaraldehyde	with	both	proteins	led	to	the	appearance	of	a	band	of	ca.	46	KDa,	compatible	with	an	HrcA-HspR	complex	(Figure	 13,	 lane	AR-X).	To	 further	confirm	the	direct	 interaction	between	CjHspR	and	
CjHrcA,	we	carried	out	a	GST	pulldown	assay.	To	this	aim,	we	expressed	and	purified	the	recombinant	 GST-HspR	 and	 GST-HrcA	 fusion	 proteins,	 which	 were	 incubated	 with	purified	recombinant	His-CjHspR.	As	a	control,	the	same	amount	of	purified	His-CjHspR	was	 incubated	 with	 a	 recombinant	 GST	 protein.	 The	 GST,	 GST-HrcA	 and	 GST-HspR	proteins	 were	 recovered	 after	 incubation	 employing	 GSH-Sepharose	 slurry,	 and	 the	protein	composition	of	the	three	samples	was	analysed	by	SDS-PAGE.			
				
																																																																																																																																																																																																																																																																													
Figure	14:		GST	pull	down	assay	of	purified	His-CjHspR	incubated	with	GST,	GST-
CjHrcA	or	GST-CjHspR	bound	to	GSH-Sepharose	slurry.		1.	Samples	analysed	with	SDS-page	2.	Western	blot	analysis	of	samples	stained	with	an	anti-His	antibody.	
R:	CjHspR,	A:	CjHrcA	and	G:	GST.		Using	 the	 GST-CjHspR	 fusion	 protein	 as	 bait,	 a	 protein	 band	 corresponding	 to	 the	expected	molecular	mass	of	CjHspR	was	detected	 (Figure	 14,	 panel	1,	 lane	R+R).	The	
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CjHspR	band	was	absent	in	the	control	sample	in	which	the	GST	bait	was	used	(Figure	
14,	panel	1,	lane	G+R).	Intriguingly,	also,	when	we	used	the	GST-CjHrcA	fusion	protein	as	bait,	we	detected	 a	protein	band	 likely	 corresponding	 to	 the	CjHspR	prey	 (Figure	 14,	panel	1,	lane	A+R).	The	same	samples	were	also	analysed	by	immunoblot	assay	stained	with	 an	 anti-His	 tag	 antibody,	 able	 to	 detect	 only	 the	 His-tagged	 CjHspR	 (Figure	 14,	panel	2).	These	data	strongly	support	the	hypothesis	of	the	propensity	of	CjHspR	to	form	homodimers,	but	also	of	a	direct	interaction	between	the	CjHrcA	and	CjHspR	repressors.	Finally,	the	dimerization	ability	of	the	two	repressors	was	investigated	using	an	 in	vivo	system	 based	 on	 the	 Bacterial	 Adenylate	 Cyclase	 Two-Hybrid	 System	 (BACTH).	 This	assay	is	based	on	the	interaction-mediated	reconstitution	of	the	recombinant	adenylate-cyclase	 enzyme	 (CyaA)	 in	 E.	 coli	 (BTH101)	 strain,	 which	 is	 defective	 for	 adenylate-cyclase	 activity.	 It	 exploits	 the	 fact	 that	 the	 catalytic	 domain	 of	 CyaA	 from	Bordetella	
pertussis	 consists	of	 two	distinct	subunits,	T25	and	T18.	The	two	subunits	are	 inactive	when	physically	separated,	but	if	they	are	brought	in	close	proximity	to	each	other,	the	CyaA	activity	will	be	reconstituted.	 In	 the	BACTH	system,	each	one	of	 the	 two	enzyme	fragments	(T25	and	T18)	is	fused	to	a	polypeptide,	CjHrcA,	or	CjHspR	in	our	case.	If	the	two	analysed	proteins	can	interact,	dimerization	of	these	hybrid	proteins	will	take	place,	resulting	 in	 functional	 complementation	 between	 T25	 and	 T18	 subunits	 and	 in	 the	reconstitution	 of	 the	 chimeric	 enzyme.	 Therefore,	 cAMP	 synthesis	 will	 occur	 and	 the	cAMP	will	interact	with	the	catabolite	activator	protein	(CPR).	The	cAMP/CRP	complex	is	 a	 pleiotropic	 regulator	 of	 gene	 transcription	 in	 E.	 coli,	 which	 can	 turn	 on	 the	expression	of	several	resident	genes,	including	lacZ	that	cods	for	the	β-galactosidase	(β-gal)	 enzymeone.	 Finally,	 the	 β-gal	 enzyme	 can	 be	 used	 as	 a	 reporter	 of	 the	 system,	detecting	the	β-gal	activity	in	a	medium	containing	the	X-gal	compound,	a	chromogenic	substrate	of	 the	enzyme.	We	assessed	the	capability	of	both	repressors	 to	 form	homo-dimers,	as	well	as	to	form	CjHrcA-CjHspR	hetero-complexes.	To	this	purpose,	we	set	up	BACTH	assays,	where	were	used	the	following	two	chimeric	proteins:	T25-CjHspR/T18-
CjHspR,	T25-CjHrcA/T18CjHrcA,	T25-CjHrcA/T18-CjHspR	or	T25-CjHspR/T18-CjHrcA.				
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Figure	 15:	 BACHT	 (Bacterial	 Adenylate	 Cyclase	 Two-Hybrid)	 System	 of	
CjHspR/CjHspR,	CjHrcA/CjHrcA	or	CjHspR/CjHrcA.	The	β-galactosidase	activity	 is	detect	growing	the	bacteria	in	LB	enriched	with	X-gal.				R:	CjHspR,	A:	CjHrcA	and	/:	adenylate	cyclase	subunits	without	target	protein.			The	 results	 are	 shown	 in	 figure	 15,	 and	 the	 β-gal	 activity	 is	 detected	 through	 the	formation	 of	 insoluble	 blue	 compounds	 as	 a	 result	 of	 the	 X-gal	 enzyme-catalyzed	hydrolysis.	Our	results	display	an	evident	β-gal	activity	in	the	homodimeric	interaction,	
CjHspR/CjHspR	(R+R),	and	CjHrcA/CjHrcA	(A+A).	Differently,	the	β-gal	activity	obtained	starting	 to	 the	 hetero-complex	 formation,	 plate	 T25-CjHrcA/T18-CjHspR	 (A+R),	 and	T25-CjHspR/T18-CjHrcA	 (R+A),	 is	 lower	 if	 compared	with	 the	 homodimeric	 resulting	one.	 However,	 it	 appears	 significant	 when	 compared	 to	 the	 three	 negative	 controls	T25/T18-CjHspR	 (/+R),	 T25/T18-CjHrcA	 (/+A),	 and	 T25/T18	 (/+/).	 Interestingly,	 the	hetero-complex	 formation	 is	 more	 appreciable	 in	 the	 T25-CjHspR/T18-CjHrcA	 (R+A)	sample	 than	 in	 the	T25-CjHrcA/T18-CjHspR	 (A+R).	This	observation	 suggests	peculiar	gemometry	of	protein	 interaction	during	 the	 formation	of	 the	CjHspR-CjHrcA	complex.	The	obtained	results	 shed	 light	on	 the	CjHspR	and	CjHrcA	oligomeric	 state	 in	vivo	 and	suggested	the	ability	of	the	two	co-regulators	to	form	hetero-complexes	in	vivo.	
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INTRODUCTION	
	
	
					B.	HS	circuit	in	Campilobacter	jejuni						A.	Campylobacter	jejuni	contamination	cycle		
1.	CjHspR	interacts	with	multiple	sites	of	the	heat	shock	promoters	
C.	High	resolution	mapping	of	HspR	binding	sites	on	heat-shock	genes’	promoters.	DNase	I	footprinting	assays	of	HspR	on	Pcbp,	Pclp,	Pgro	and	Phrc	
promoters	(panels	A,	B,	C	and	D).	Radiolabelled	DNA	probes	were	incubated	with	increasing	concentrations	of	the	HspR	recombinant	protein	(0,	11,	
22,	45,	90,	180	and	360	nM	HspR;	lanes	1	to	6,	respectively)	at	room	temperature	and	subjected	to	limited	DNase	I	digestion.	In	each	panel,	on	the	
right	the	grey	boxes	highlight	regions	of	DNase	I	protection	and	the	black	arrowheads	indicate	bands	of	hypersensitivity	to	DNase	I	digestion;	while	
on	the	left	bent	arrows	indicate	the	transcriptional	start	site	and	vertical	open	arrows	depict	the	open	reading	frames;	numbers	refer	to	the	positions	
with	respect	to	the	transcriptional	start	sites.		
C	
2.	Characterization	of	the	HAIR	consensus	sequence	in	C.	jejuni		
High	affinity	HAIR			 Total	HAIR			 Low	affinity	HAIR			
Pgro	
CTTTAGT-------ATAAAAT
CTTTAGT-------ACTAAAC
CTTTAAA-------ATTTATA
PcbpA	
CTTGATT-------GCTAAAG
CTTGAGT-------ATTTATA
PhrcA	
CTTATAA-------ACTAATA
CTTTAGT-------ACTAAAT
CTTATAA-------ACTAATA
	PclpB	
CTTTAGT-------TGTCAAG
CTTTATT-------TAGACTT
D
E	
D.	HAIR	sequences	characterized	through	DNase	I	footprinting	assays	(C),	in	blue	the	low	affinity	and	in	read	the	high	affinity	HAIR,	and	their		
Weblogo	representations	(E).								
DNase	 I	 footprinting	assays	of	HspR	on	wild	 type	Pcbp	 (panel	A)	or	on	mutant	MHL	 (panel	B),	
MHR	 (panel	 C)	 and	MH	 (panel	 D)	 probes	 (F),	 on	wild	 type	 Pgro	 (panel	 A)	 or	 on	mutant	MHL	
(panel	B),	MHR	 (panel	C)	and	MH	 (panel	D)	probes	 (G)	and	on	wild	 type	Pgro	 (panel	A)	or	on	
mutant	MH	 (panel	 B),	MM	 (panel	 C)	 and	ML	 (panel	D)	 probes	 (H).	 Radiolabelled	DNA	probes	
were	incubated	with	different	concentrations	of	recombinant	HspR	protein	(0,	22,	45,	90,	180,	
360	 and	 720	 nM	 HspR;	 lanes	 1	 to	 7)	 at	 room	 temperature	 and	 subjected	 to	 partial	 DNase	 I	
digestion.	On	the	right	of	each	panel,	grey	boxes	depict	the	regions	of	DNase	 I	protection	and	
black	arrowheads	indicate	bands	of	hypersensitivity	to	DNase	I	digestion.	On	the	left,	schematic	
representation	of	the	promoter	region,	where	the	bent	arrows	indicate	the	transcriptional	start	
site,	 vertical	open	arrows	depict	 the	open	 reading	 frame;	numbers	 refer	 to	 the	positions	with	
respect	to	the	transcriptional	start	sites.	The	wild	type	HAIR	sequences	are	represented	by	grey	
boxes,	while	the	mutated	sequences	are	represented	by	white	boxes.		
3.	The	HAIR	sequence	motif	is	essential	for	CjHspR		binding	to	DNA	and	high-affinity	binding	sites	act	
as	recruitment	centers	of		CjHspR	to	promoters						
F	 G
H
4.	CjHrcA	specifically	binds	Pgro	and	Phrc	
I.	High	resolution	mapping	of	CjHrcA	binding	sites	on	heat-shock	genes’	promoters.	DNase	I	
footprinting	assays	of	HrcA	on	Pgro	and	Phrc	promoters	(panels	E	and	F).	Radiolabelled	DNA	
probes	were	 incubated	with	 different	 concentrations	 of	 recombinant	HrcA	 protein	 (0,	 11,	
22,	 45,	 90,	 180	 and	 360	 nM	 HrcA;	 lanes	 1	 to	 6,	 respectively)	 at	 room	 temperature	 and	
subjected	to	limited	DNase	I	digestion.	In	each	panel,	on	the	right	the	grey	boxes	highlight	
regions	of	DNase	I	protection	and	the	black	arrowheads	indicate	bands	of	hypersensitivity	to	
DNase	 I	digestion;	while	on	 the	 left	bent	arrows	 indicate	 the	 transcriptional	 start	 site	and	
vertical	open	arrows	depict	 the	open	 reading	 frames;	numbers	 refer	 to	 the	positions	with	
respect	 to	 the	 transcriptional	 start	 sites.	 L.	 CIRCE	 sequences	 confirmed	 by	 DNase	 I	
footprinting	assays.		
	
I	
Pgro:																																																																				Phrc:	
TTATCACTC---------GAGTGCTAA  CTAGCAATC---------GAGTGCTAG 
L
5.	CjHspR	and	CjHrcA	mutual	cooperative	effect	on	DNA	binding	
to	specific	operators		
M.	DNase	I	footprinting	assays	of	CjHspR	on	Pgro	(0,	11,	22,	45,	90,	180	and	360	nM,	lanes	1	to	6	and	7	to	12;	panel	A)	with	GST	(360	nM,	lines	1	
to	6)	or	CjHrcA	(360	nM,	lines	7	to	12)	and	CjHrcA	(0,	11,	22,	45,	90,	180	and	360	nM,	lanes	1	to	6	and	7	to	12;	panel	B)	with	GST	(180	nM,	lines	1	
to	6)	or	CjHspR	(360	nM,	lines	7	to	12).	In	each	panel,	on	the	right	grey	boxes	highlight	the	regions	of	DNase	I	protection	and	the	black	arrowheads	
indicate	bands	of	hypersensitivity	 to	DNase	 I	 digestion	of	CjHspR	or	CjHrcA,	panel	A	and	B	 respectively.	On	 the	 left,	 bent	 arrows	 indicate	 the	
transcriptional	start	site,	vertical	open	arrows	depict	the	open	reading	frame;	numbers	refer	to	the	positions	with	respect	to	the	transcriptional	
start	sites.	The	HAIR	and	CIRCE	sequences	are	indicated	by	dark	and	light	grey	boxes	respectively.		
	
M
The	heat-shock	response	is	a	mechanism	of	cellular	protection	that	triggers	a	sudden	increase	in	the	cellular	concentration	of	different	proteins,	
including	molecular	chaperones	and	proteases,	to	preserve	the	protein	folding	that	is	damaged	by	the	stress	conditions	(1).	This	makes	the	heat-		
shock	 response	a	 central	pathway	 in	host-pathogen	 interaction,	 that	plays	a	 crucial	 role	 to	
establish	 successful	 infections	 and	 promote	 host	 colonization.	 In	 the	 human	 pathogen	
Campylobacter	jejuni,	temperature	variations	may	be	used	to	switch	between	commensalism	
(chicken	 reservoir,	 42°C)	 to	 pathogenesis	 (human	 host,	 37°C)	 (2)	 (A),	 additionally	 the	 heat-
shock	proteins	GroEL	and	GroES	are	immunogenic	in	rabbits	(3)	and	the	DnaJ	mutation	reduce	
the	 ability	 to	 colonize	 chicken	 (2).	 In	C.	 jejuni	 the	 heat-shock	 response	 to	 thermic	 stress	 is	
controlled	 by	 a	 regulatory	 circuit,	 which	 acts	 at	 the	 transcriptional	 level	 and	 involves	 the	
repressors	 CjHspR	 and	 CjHrcA	 (4)	 (B).	 Previous	 genome-wide	 approaches	 identified	 the	
regulons	 of	 these	 heat-shock	 repressors	 (4,5),	 however	 a	molecular	 characterization	 of	 the	
mechanism	underpinning	CjHrcA	and	CjHspR	regulatory	functions	is	still	missing.		
OUTLOOK				
CONCLUSIONS	
This	work	highlights	a	complex	architecture	of	DNA-binding,	in	
which	CjHspR	 interacts	with	multiple	 operators	 on	 the	 same	
promoter.	The	operators	show	a	different	binding	affinity	and	
allow	a	modular	regulation	of	the	target	 	genes.	Additionally,	
an	higher	complexity	 is	observed	on	co-regulated	promoters,	
where	each	regulator	has	a	positive	effect	on	the	DNA-binding	
ability	of	the	regulatory	partner.	
•  Functional	characterization	of	HspR	on	promoters	harboring	different	mutations	of	the	HAIR	sequences	in	vivo.		
•  Preliminary	results	suggest	the	existence	of	a	direct	 interaction	between	HrcA	and	HspR	(panels	N,	O,	P),	possibly	explaining	the	mutual	cooperative	effect	on	
DNA	binding	observed	(Figure	M)					
							MW		AR-X	AR	AA-X	AA										RR-X				RR											N O
P.		GST	pulldown	assay	of	purified	His-CjHspR	incubated	with	GST,	GST-CjHrcA	or	GST-CjHspR	bound	to	GSH-Sepharose	slurry.																			
a.	Samples	analysed	with	SDS-page		b.	Western	blot	analysis	of	samples	stained	with	an	anti-His	antibody.	
	
																																																																																																																																																																																																																																																																															
P	
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GST-CjHrcA	
GST-CjHspR	
GST	
CjHspR	
a	
b	
CjHspR	
R+R						A+R							G+R		
O.	BACHT	(Bacterial	Adenylate	Cyclase	Two-Hybrid)	System	N.	Cross	linking	assay	of	CjHspR+CjHrcA,	CjHrcA+CjHrcA	and	
CjHspR+CjHspR	incubated	with	or	without	glutaraldehyde.	
R+R																				A+A		
							A+R																			R+A		 							/+R														/+/	
							/+A		
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Discussion		
	The	 characterization	of	 the	heat-shock	 circuit	 in	C.	 jejuni	was	developed	 starting	 from	the	 information	 that	 hspR	 and	 hrcA	 are	 involved	 in	 the	 regulation	 of	 the	 heat-shock	genes.	 Moreover,	 the	 cis-element	 associated	 with	 the	 two	 repressors,	 the	 HAIR	 and	CIRCE	motifs,	were	identified	in	the	promoter	regions	of	the	most	important	chaperones	and	 proteases	 genes.	 Therefore,	 we	 set	 up	 various	 in	 vitro	 binding	 experiments	 to	investigate	at	the	molecular	level	the	HspR	and	HrcA	interaction	with	different	putative	target	promoters	in	C.	jejuni.	The	characterization	of	the	HspR	binding	on	the	heat-shock	promoters	 allowed	 us	 to	 identify	 an	 intriguing	 scenario.	 The	 HspR	 operators	 are	composed	 of	 multiple	 binding	 sites	 located	 in	 a	 single	 promoter,	 each	 one	 exhibiting	different	repressor	affinity	(fig.	 4).	The	sequence	analysis	evidenced	that	each	binding	site	is	constituted	of	one	HAIR	motif.	This	evidence	is	in	contrast	with	results	obtained	in	
H.	pylori	in	which	each	operator	carries	only	one	HAIR	motif,	even	though	the	binding	of	HspR	is	extended	outside	of	the	sequence	motif	(Pepe	et	al.,	2018).	Combined	analysis	of	high-	and	low-affinity	HAIR	sequences	alignment	(fig.5),	and	DNase	I	footprinting	assays	on	mutated	promoter	sequences	(fig.	6-7)	elucidated	the	specific	HAIRs’	features	on	the	root	of	 their	distinct	HspR	affinity.	 Indeed,	 the	binding	hierarchy	of	HAIRs	on	a	 single	promoter	appears	to	be	a	consequence	of	both	the	IR’s	second	emisite	conservation	and	theHAIR	specific	position	 respect	 to	 the	other	HspR	binding	 sites	 located	on	 the	 same	promoter.	 This	 evidence	 allowed	 to	 postulate	 a	 regulatory	 mechanism,	 where	 a	 first	HspR	 interaction	 with	 the	 promoter	 on	 the	 high-	 affinity	 sites	 acts	 as	 core	 able	 to	enhance	 the	 binding	 of	 other	HspR	 functional	 units	 on	 the	 flanking	 binding	 sites.	 The	successive	bindings	might	stabilize	the	HspR	interactions	on	the	target	promoters,	and	consolidate	the	repressor-promoter	complex	(fig.	 16).	Moreover,	 the	described	results	allow	speculating	on	the	role	 that	may	have	different	HspR	binding	sites	with	variable	repressor	 affinity	 in	 a	 cellular	 environment	 able	 to	 modulate	 the	 concentration	 of	functional	 HspR.	 Indeed,	 this	 peculiar	 binding	 architecture	 may	 reflect	 in	 the	 fine	regulation	of	the	target	genes	expression,	adapted	to	the	specific	intracellular	condition.			
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Figure	16:		Schematic	representation	of	the	HspR	recruitment	modality	on	target	promoter.		Although	 HspR	 alone	 can	 repress	 Pcbp	 and	 PclpB	 promoters,	 both	 HspR	 and	 HrcA	regulators	 are	 necessary	 to	 repress	 Pgro	 and	 Phrc	 transcription	 under	 physiological	growth	conditions	(Holmes	et	al.,	2012).		While	HAIR-containing	operators	located	in	the	core	promoter	region	characterize	the	first	class	of	promoters,	the	latter	type	owns	the	core	 HspR-operator	 far	 upstream	 the	 transcriptional	 start	 site	 (TSS)	 to	 an	 atypical	position	for	a	transcriptional	repressor.	A	detailed	in	vitro	characterization	of	HrcA	and	HspR	 DNA-binding,	 presented	 in	 this	 study,	 demonstrated	 that	 their	 operators	 are	arranged	in	tandem	on	this	second	group	of	promoters,	and	confirmed	that	the	CIRCE-containing	operators	overlap	the	TSS.	These	observations	are	consistent	with	the	typical	architecture	for	dually	regulated	promoters	(Roncarati	et	al.,	2017),	and	support	the	role	of	 HrcA	 as	 HspR	 co-repressor	 also	 in	 C.	 jejuni.	 Different	 indications	 of	 interactions	between	the	repressor	units	involved	in	this	complex	binding	architecture	are	provided	in	 the	 study	 (fig.13-14-15).	 These	 added	 to	 experimental	 evidence	 of	 a	 mutual	cooperative	 effect	 of	 the	 two	 heat-shock	 repressors	 on	 the	 co-regulated	 promoters	(fig.12),	 support	 a	DNA-binding	mechanism,	where	 a	 first	 binding	 event	promotes	 the	interaction	 of	 the	 partner	 repressor	 (fig.17)	 and	 improves	 the	 formation	 of	 a	 stable	repressive	 complex.	 Furthermore,	 the	 multiple	 interconnections	 pattern	 that	 allows	between	the	proteins	and	DNA	operators	might	stabilize	the	binding	of	the	repressors,	and	consolidate	the	protein-DNA	complex	in	our	model.		
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Figure	17:	Model	of	transcriptional	regulators	recruitment	mechanism	on	heat-shock	promoter.	
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acts	as	core	able	to	enhance	the	binding	of	other	HspR	functional	units	on	the	flanking	binding	sites.	The	successive	bindings	might	stabilize	the	HspR	interaction	on	the	target	promoters,	 and	 consolidate	 the	 repressor-promoter	 complex	 (fig.	 16).	 Moreover,	 the	described	 results	 allow	 speculating	 on	 the	 role	 that	may	 have	 different	HspR	 binding	sites	 with	 variable	 repressor	 affinity	 in	 a	 cellular	 environment	 able	 to	 modulate	 the	concentration	of	functional	HspR.	Indeed,	this	peculiar	binding	architecture	may	reflect	in	the	fine	regulation	of	the	target	genes	expression,	adapted	to	the	specific	intracellular	condition.		Although	 HspR	 alone	 can	 repress	 Pcbp	 and	 PclpB	 promoters,	 both	 HspR	 and	 HrcA	regulators	 are	 necessary	 to	 repress	 Pgro	 and	 Phrc	 transcription	 under	 physiological	growth	conditions	(Holmes	et	al.,	2012).		While	HAIR-containing	operators	located	in	the	core	promoter	region	characterize	the	first	class	of	promoters,	the	latter	type	owns	the	core	 HspR-operator	 far	 upstream	 the	 transcriptional	 start	 site	 (TSS)	 to	 an	 atypical	position	for	a	transcriptional	repressor.	A	detailed	in	vitro	characterization	of	HrcA	and	HspR	 DNA-binding,	 presented	 in	 this	 study,	 demonstrated	 that	 their	 operators	 are	arranged	 in	 tandem	 on	 this	 second	 promoters	 group,	 and	 confirmed	 that	 the	 CIRCE-containing	operators	overlap	the	TSS.	These	observations	are	consistent	with	the	typical		
	
	
Figure	17:	Model	of	transcriptional	regulators	recruitment	mechanism	on	heat-shock	promoter.		
A
B
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Conclusion				In	 this	 study,	we	started	 the	characterization	of	 the	heat-shock	 regulatory	circuit	 in	C.	
jejuni.	 Our	 results	 support	 a	 model	 (fig.	 18)	 in	 which	 HspR	 and	 HrcA	 cooperatively	repress	 transcription	 of	 the	 heat-shock	 genes.	 More	 in	 detail,	 HspR	 alone	 controls	transcription	 from	 two	 promoters,	 the	 Pcpb	 and	 the	 Pclp,	 thus	 autoregulates	 its	expression.	 Differently,	 both	 the	 transcriptional	 factors	 HspR	 and	 HrcA	 regulate	 the	majority	of	chaperones	and	proteases	genes	involved	in	the	heat-shock	response	and	the	
hrcA	transcription.			
	
Figure	18:	Regulatory	circuit	of	HspR	and	HrcA	on	C.	jejuni.		This	 work	 allowed	 to	 elucidate	 at	 the	 molecular	 level	 the	 repressors-promoters	interactions,	 revealing	 an	 intricate	 binding	 site	 architecture,	 which	 hypothesizes	 a	peculiar	 repressors-DNA	 interaction	 structure,	 of	 which	 a	 more	 detailed	characterization	 would	 be	 advantageous	 to	 explain	 the	 basis	 of	 the	 cooperative	regulation	mechanism.	Moreover,	 an	 investigation	 of	 the	 HspR	 and	 HrcA	 pathway	 by	which	 the	 two	 transcriptional	 factors	 can	 sense	 the	 increase	 in	 temperature,	 or	more	generally,	 the	heat	stress	condition,	 is	 indispensable	to	conclude	the	heat-shock	circuit	characterization.	
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Materials	and	methods	
	
6.1.1	Bacterial	strains	and	media	
	
E.	 coli	 strain	 DH5α	 was	 used	 for	 cloning	 and	 plasmid	 preparation,	 E.	 coli	 strain	BL21(DE3)	 was	 utilized	 for	 the	 overexpression	 of	 recombinant	 proteins,	 and	 E.	 coli	strain	BTH101	was	used	for	BACTH	assays.	E.	coli	strains	were	cultured	in	Luria-Bertani	medium.	C.	jejuni	NCTC11168	cells	were	recovered	from	frozen	stocks	on	Brucella	broth	agar	plates	containing	5%	fetal	calf	serum,	in	a	9%	CO2-91%	air	atmosphere	at	37	°C	and	95%	humidity	 in	a	water-jacketed	 incubator	 (Thermo	Scientific).	Liquid	cultures	were	grown	 in	Brucella	Broth	 supplemented	with	5%	 fetal	 calf	 serum	with	 gentle	 agitation	(120	 rpm)	 under	 microaerophilic	 conditions	 (Oxoid).	 When	 required,	 kanamycin	 or	chloramphenicol	was	added	to	final	concentrations	of	25	and	30	μg	ml-1,	respectively.			
Table	1:	Bacterial	strains	used	in	this	study.	
Bacterial	strain	 Genotype	 Reference	
Escherichia	coli	DH5α	 supE44	ΔlacU169	(φ80	lacZΔM15)	
hsdR17	recA1	endA1	gyrA96	thi-1	relA1	
Hanahan,	1983	
Escherichia	coli	BL21(DE3)	 hsdS	gal	(λcIts857	ind1	Sam7	nin5	lacUV5-T7	gene	1)	 Studier	et	al.,	1990	
Campylobacter	jejuni	NCTC-11168	 isolated	from	a	case	of	human	enteritis	in	the	UK,	wild	type	 Parkhill	et	al.,	2000;	Gaynor	et	al.,	2004	
Escherichia	coli	BTH101	 cya-99,	araD139,	galE15,	galK16,	rpsL1	
(Str	r),	hsdR2,	mcrA1,	mcrB1	 Battesti	et	al.,	2012	
	
6.1.2	DNA	manipulation		DNA	 manipulations	 were	 performed	 as	 described	 by	 Sambrook	 et	 al.	 (1989).	 All	restriction	 and	 modification	 enzymes	 were	 used	 according	 to	 the	 manufacturers’	instructions	 (New	 England	 Biolabs).	 Mini	 and	 midi	 scale	 plasmid	 preparations	 were	carried	 out	 with	 the	 Nucleospin	 plasmid	 and	 the	 NucleoBond	 Xtra	 Midi	 plasmid	purification	 kits,	 respectively	 (Macherey-Nagel).	 DNA	 fragments	 or	 PCR	 amplification	
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products	for	cloning	purposes	were	purified	from	agarose	gels	with	the	NucleoSpin	Gel	and	PCR	Clean-up	kit	(Macherey-Nagel).		
Table	2:	Plasmids	used	in	this	study.	
	Plasmid	 	Description	 	Reference	pGEM-T-Easy	 Cloning	vector,	Ampr	 Promega	pGEM-T-Easy-CjPcbp	 pGEM-T-Easy	derivative	containing	a	285	bp	PCR	fragment	(oligonucleotides	
CjPcbp-F	and	CjPcbp-R)	that	encompassing	the	htrA-cbpA	intergenic	region	and	the	5’	parts	of	the	tow	genes.	
This	study	
pGEM-T-Easy-CjPclp	 pGEM-T-Easy	derivative,	containing	a	198	bp		PCR	fragment	(oligonucleotides	
CjPclp-F	and	CjPclp-R)	that	comprises	the	Pclp	promoter.	
This	study	
pGEM-T-Easy-CjPgro	 pGEM-T-Easy	derivative	carrying	a	261	bp	PCR	fragment	(oligonucleotides	
CjPgro-F	and	CjPgro-R)	that	encompassing	the	Pgro	promoter.	
This	study	
pGEM-T-Easy-CjPhrc	 pGEM-T-Easy	derivative	containing	a	421	bp	PCR	fragment	(oligonucleotides	
CjPhrc-F	and	CjPhrc-R)	that	comprises	the	Phrc	promoter.	
This	study	
pGEM-T-Easy-CjPcbpWT	 pGEM-T-Easy	derivative,	containing	a	89	bp	fragment	deriving	from	ssDNA	
CjPcbpWT-F	and		CjPcbpWT-R		annealing.	
This	study	
pGEM-T-Easy-CjPcbpMHL	 pGEM-T-Easy	derivative,	containing	a	89	bp	fragment	deriving	from	ssDNA	
CjPcbpMHL-F	and		CjPcbpMHL-R		annealing.	
This	study	
pGEM-T-Easy-CjPcbpMHR	 pGEM-T-Easy	derivative,	containing	a	89	bp	fragment	deriving	from	ssDNA	
CjPcbpMHR-F	and		CjPcbpMHR-R		annealing.	
This	study	
pGEM-T-Easy-CjPcbpMH	 pGEM-T-Easy	derivative,	containing	a	89	bp	fragment	deriving	from	ssDNA	
CjPcbpMH-F	and		CjPcbpMH-R		annealing.	
This	study	
pGEM-T-Easy-CjPgroWT	 pGEM-T-Easy	derivative	containing	a	169	bp	PCR	fragment	obtained	from	the	annealing	and	amplification	of	the	ssDNA		CjPgroWT-F	and		CjPgroWT-R.		
This	study	
pGEM-T-Easy-CjPgroMHL	 pGEM-T-Easy	derivative	containing	a	169	bp	PCR	fragment	obtained	from	the	annealing	and	amplification	of	the	 This	study	
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ssDNA		CjPgroMHL-F	and		CjPgroMHL-R.	pGEM-T-Easy-CjPgroMHR	 pGEM-T-Easy	derivative	containing	a	169	bp	PCR	fragment	obtained	from	the	annealing	and	amplification	of	the	ssDNA		CjPgroMHR-F	and		CjPgroMHR-R.	
This	study	
pGEM-T-Easy-CjPgroMH	 pGEM-T-Easy	derivative	containing	a	169	bp	PCR	fragment	obtained	from	the	annealing	and	amplification	of	the	ssDNA		CjPgroMH-F	and		CjPgroMH-R.	
This	study	
pGEM-T-Easy-CjPgroMM	 pGEM-T-Easy	derivative	containing	a	169	bp	PCR	fragment	obtained	from	the	annealing	and	amplification	of	the	ssDNA		CjPgroMM-F	and		CjPgroMM-R.	
This	study	
pGEM-T-Easy-CjPgroML	 pGEM-T-Easy	derivative	containing	a	169	bp	PCR	fragment	obtained	from	the	annealing	and	amplification	of	the	ssDNA		CjPgroML-F	and		CjPgroML-R.	
This	study	
pET15b	 Expression	vector,	allowing	N-terminal	histidine-tag	gene	fusion;	Ampr	 Novagen	pET15b-hrcA	 pET15b	derivative	containing	the	hrcA	coding	sequence	amplified	by	PCR	with	oligonucleotides	CjhrcA15b-F	and	
CjhrcA15b-R	on	chromosomal	DNA	of	C.	
jejuni,	digested	with	restriction	enzymes	NdeI	and	XhoI	and	ligated	to	pET15b.	
This	study	
pET15b-hspR	 pET15b	derivative	containing	the	hspR	coding	sequence	amplified	by	PCR	with	oligonucleotides	CjhspR15b-F	and	
CjhspR15b-R	on	chromosomal	DNA	of	C.	
jejuni,	digested	with	restriction	enzymes	NdeI	and	XhoI	and	ligated	to	pET15b.	
This	study	
pGEX-NN	 Expression	vector,	allows	N-terminal	GST	gene	fusion;	Ampr.	 Novagen	pGEX-NN-hrcA	 pGEX-NN	derivative	containing	the	hrcA	coding	sequence	excised	from	pET15b-
hrcA	by	NdeI/XhoI.	 This	study	pGEX-NN-hspR	 pGEX-NN	derivative	carryng	the	hspR	gene	excised	from	pET15b-hspR	by	NdeI/XhoI.	 This	study	pUT18C	 Expression	vector,	allows	N-terminal	T18	gene	fusion;	Ampr.	 Battesti	A,	et	al.,	2012		pUT18C-hrcA	 pUT18C	derivative	carrying	the	hrcA	coding	sequence	amplified	by	PCR	(oligonucleotides	CjhrcA-F	and	CjhrcA-R)	and	digested	BamHI/KpnI.	
This	study	
pUT18C-hspR	 pUT18C	derivative	containing	the	hspR	coding	sequence	amplified	by	PCR	with	oligonucleotides	CjhspR-F	and	CjhspR-R,	 This	study	
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Table	3.	Oligonucleotides	used	in	this	study.	
	
Oligonucleotide	 Sequence	(5’-3’)a	 Restriction	
recognition	site	
CjuphrcA-F	 ATGCGGCCGCGCTTCCATGGGTGTGCG	 NotI		
CjuphrcA-R	 ATGGATCCCGAAGCAGGTATGCAAAGG	 BamHI	
CjdownhrcA-F	 ATGGATCCGAAGGTTTTATGGGGCTTAAG	 BamHI	
CjdownhrcA-R	 ACCTCGAGGCTACACTAACTTTGGTTGGGC	 XhoI	
CjuphspR-F	 ATGCGGCCGCGGACGCTCAAGAGGGGG	 NotI	
CjuphspR-R	 ACGGATCCGGTTCATCATAATGCTGTTCC	 BamHI	
CjdownhspR-F	 CTGGATCCGCGGCTAGTAAAGCCGTTG	 BamHI	
CjdownhspR-R	 GACTCGAGGTGCTGAAATTAAACTGGTAAAAAGG	 XhoI	
Cj∆hrcA-F	 GCACAAGATAGAAGTGTGATAGGTAAACC	 	
Cj∆hrcA-R	 GGATTACTTTGCTCTCGCCG	 	
Cj∆hspR-F	 GATCTCTTTGGAGGAGGCTTTGG	 	
Cj∆hspR-R	 AGCACCTGCTATAAAAGCACCC	 	
CjhrcA15b-F	 CCGCATATGATGAAAAGTCGAGATAAAAAGG	 NdeI	
CjhrcA15b-R	 GCGCTCGAGTCACGCCGCCTCCTTTATATATTG	 XhoI	
CjhspR15b-F	 CCGCATATGGAACAGCATTATGATGAACC	 NdeI	
CjhspR15b-R	 CGGCTCGAGTTATTTTTTCTCATAAAAAATCAAATCAAAGC	 XhoI	
CjPcbp-F	 GGATCCCTTGCAGCAAATAAAGCACTTGCTAAAC	 BamHI	
CjPcbp-R	 CTCGAGGCTAACTCCAAGAGTTTCGTATAAACTATTC	 XhoI	
CjPclp-F	 GGATCCGCATATTATCAGTTAAAAAATCTTGTATATTTGCC	 BamHI	
CjPclp-R	 CTCGAGGATATTCAAAGTATAGAAGAATTAAACAAGGC	 XhoI	
CjPgro-F	 GGATCCGCACAACAACAAAAGCTACAATGCC	 BamHI	
CjPgro-R	 CTCGAGCGCGTTTAACTAGAACACGCTTTCCTAAAGG	 XhoI	
CjPhrc-F	 GGATCCGAAGGAAGAAGAATGTATATTTCTATCAATGG	 BamHI	
digested	with	BamHI	and	KpnI.	pKT25	 Expression	vector,	allows	N-terminal	T25	gene	fusion;	Kmr.	 Battesti	A,	et	al.,	2012	pKT25-hrcA	 pKT25	derivative	containing	the	hrcA	coding	sequence,	PCR	amplified	(oligonucleotides	CjhrcA-F	and	CjhrcA-R),	digested	BamHI/KpnI.	
This	study	
pKT25-hspR	 pKT25	derivative	carrying	the	hspR	coding	sequence	amplified	by	PCR	(oligonucleotides	CjhspR-F	and	CjhspR-R)	and	digested	with	restriction	enzymes	BamHI	and	KpnI.	
This	study	
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CjPhrc-R	 CTCGAGCCAATAGGTGCATTATCCAAAAGATAAG	 XhoI	
CjhrcA-F	 GCGGGATCCGATGATGAAAAGTCGAGATAAAAAGG	 BamHI	
CjhrcA-R	 CGCGGTACCTCACGCCGCCTCCTTTATATATTG	 KpnI	
CjhspR-F	 GCGGGATCCGATGGAACAGCATTATGATGAACC	 BamHI	
CjhspR-R	 CGCGGTACCTTATTTTTTCTCATAAAAAATCAAATCAAAGC	 KpnI	
CjPcbpWT-F	 TAAATAAAACCTTGAGTGATAAAAATTTATAAAACTTGATTGACTTAGGCTAAAGTTTATGTTATAATTTAATCCTCTATATAATCAAA	 	
CjPcbpWT-R	 TTGATTATATAGAGGATTAAATTATAACATAAACTTTAGCCTAAGTCAATCAAGTTTTATAAATTTTTATCACTCAAGGTTTTATTTAA	 	
CjPcbpMHL-F	 TAAATAAAACCTTGAGTGATAAAAATTTATAAAAGAACTAAGACTTAGGCTAAAGTTTATGTTATAATTTAATCCTCTATATAATCAAA	 	
CjPcbpMHL-R	 TTGATTATATAGAGGATTAAATTATAACATAAACTTTAGCCTAAGTCTTAGTTGTTTTATAAATTTTTATCACTCAAGGTTTTATTTAA	 	
CjPcbpMHR-F	 TAAATAAAACCTTGAGTGATAAAAATTTATAAAACTTGATTGACTTAGCGATTTCTTTATGTTATAATTTAATCCTCTATATAATCAAA	 	
CjPcbpMHR-R	 TTGATTATATAGAGGATTAAATTATAACATAAAGAAATCGCTAAGTCAATCAAGTTTTATAAATTTTTATCACTCAAGGTTTTATTTAA	 	
CjPcbpMH-F	 TAAATAAAACCTTGAGTGATAAAAATTTATAAAAGAACTAAGACTTAGCGATTTCTTTATGTTATAATTTAATCCTCTATATAATCAAA	 	
CjPcbpMH-R	 TTGATTATATAGAGGATTAAATTATAACATAAAGAAATCGCTAAGTCTTAGTTGTTTTATAAATTTTTATCACTCAAGGTTTTATTTAA	 	
CjPgroWT-F	 AAAATCTTTTTCATTTTTATCCTTTAGTTTATTTTATAAAATAACTTTAGTCTATAAAACTAAACTTTTATAAATATTTTAATTTAAAGTATTGACAAAA	 	
CjPgroWT-R	 CCATCCTTAAAAATATTGATTTTAGCACTCTTTAATTTAGAGTGATAATATCATACTATAAAAAATGAATTTTGTCAATACTTTAAATTAAAATATTTATAAAAG	
	
CjPgroMHL-F	 AAAATCTTTTTCATTTTTATCCTTTAGTTTATTTTATAAAATAAGAAATCACTATAAAACTAAACTTTTATAAATATTTTAATTTAAAGTATTGACAAAA	 	
CjPgroMHL-R	 CCATCCTTAAAAATATTGATTTTAGCACTCTTTAATTTAGAGTGATAATATCATACTATAAAAAATGAATTTTGTCAATACTTTAAATTAAAATATTTATAAAAG	
	
CjPgroMHR-F	 AAAATCTTTTTCATTTTTATCCTTTAGTTTATTTTATAAAATAACTTTAGTCTATAAATGATTTCTT 	
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TTATAAATATTTTAATTTAAAGTATTGACAAAA	
CjPgroMHR-R	 CCATCCTTAAAAATATTGATTTTAGCACTCTTTAATTTAGAGTGATAATATCATACTATAAAAAATGAATTTTGTCAATACTTTAAATTAAAATATTTATAAAAG	
	
CjPgroMH-F	 AAAATCTTTTTCATTTTTATCCTTTAGTTTATTTTATAAAATAAGAAATCACTATAAATGATTTCTTTTATAAATATTTTAATTTAAAGTATTGACAAAA	 	
CjPgroMH-R	 CCATCCTTAAAAATATTGATTTTAGCACTCTTTAATTTAGAGTGATAATATCATACTATAAAAAATGAATTTTGTCAATACTTTAAATTAAAATATTTATAAAAG	
	
CjPgroMM-F	 AAAATCTTTTTCATTTTTATCGAAATCATTATTTTTATTTTAAACTTTAGTCTATAAAACTAAACTTTTATAAATATTTTAATTTAAAGTATTGACAAAA	
	
CjPgroMM-R	 CCATCCTTAAAAATATTGATTTTAGCACTCTTTAATTTAGAGTGATAATATCATACTATAAAAAATGAATTTTGTCAATACTTTAAATTAAAATATTTATAAAAG	
	
CjPgroML-F	 AAAATCTTTTTCATTTTTATCCTTTAGTTTATTTTATAAAATAACTTTAGTCTATAAAACTAAACTTTATATTTAATTTTAAAAATTTGTATTGACAAA	 	
CjPgroML-R	 CCATCCTTAAAAATATTGATTTTAGCACTCTTTAATTTAGAGTGATAATATCATACTATAAAAAATGAATTTTGTCAATAGAAATTTTTAAAATTAAATATAAAG	
	
a	Restriction	sites	added	for	cloning	purposes	are	underlined.	
	
6.1.2.1	Mutant	DNA	fragments	construction	The	 DNA	 fragments	 CjPcbpWT,	 CjPcbpMHL,	 CjPcbpMHR,	 and	 CjPcbpMH	 are	 obtained	from	the	ssDNA	sequences	CjPcbpWT-F	and	CjPcbpWT-R,	CjPcbpMHL-F	and	CjPcbpMHL-R,	 CjPcbpMHR-F	 and	 CjPcbpMHR-R,	 and	 CjPcbpMH-F	 and	 CjPcbpMH-R	 (table	 3).	 The	couples	 of	 complementary	 ssDNA	 are	 mixed	 and	 boiled	 to	 100	 °C	 for	 10	 min,	 and	gradually	 chilled	 to	 room	 temperature,	 to	 obtain	 dsDNA.	 Finally,	 dsDNA	 are	 purified	from	 agarose	 gel.	 Differently,	 the	 DNA	 fragments	 CjPgroWT,	 CjPgroMHL,	 CjPgroMHR,	
CjPgroMH,	 CjPgroMM,	 and	 CjPgroML	 are	 obtained	 starting	 from	 CjPgroWT-F	 and	
CjPgroWT-R,	 CjPgroMHL-F	 and	 CjPgroMHL-R,	 CjPgroMHR-F	 and	 CjPgroMHR-R,	
CjPgroMH-F	 and	 CjPgroMH-R,	 CjPgroMM-F	 and	 CjPgroMM-R,	 and	 CjPgroML-F	 and	
CjPgroML-R	(table	3).	The	couples	of	ssDNA	are	used	as	primers	and	template	in	a	PCR	reaction	to	obtain	the	whole	dsDNA	fragments.		
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6.1.3	RNA	isolation			Bacterial	cells	were	gently	harvested	pipetting	10	ml	of	liquid	cultures	into	a	15	ml	tube	containing	1.25	ml	of	 ice-cold	EtOH/Phenol	 stop	solution	 (5%	water-saturated	phenol	pH	4.5	in	ethanol).	Cells	were	spun	down	at	4000	rpm	for	10	min	at	4	°C;	then,	bacterial	pellets	were	resuspended	in	800	μl	of	lysis	buffer	(10	mM	Tris-HCl	pH	8.0,	1	mM	EDTA	pH	 8.0,	 0.5	mg/ml	 lysozyme)	 and	 transferred	 in	 2	ml	microfuge	 tubes.	 Samples	were	treated	with	 80	 μl	 of	 10%	 SDS,	 placed	 in	 a	water	 bath	 at	 65	 °C	 for	 2	min	 before	 the	addition	of	88	μl	of	1	M	NaOAc	pH	5.2,	and	1	ml	of	water-saturated	phenol	pH	4.5.	The	tubes	were	incubated	in	a	65	°C	water	bath	for	6	min,	inverting	6-10	times	every	40	s,	then	chilled	on	 ice	and	centrifuged	at	max	speed	(14000	rpm)	 for	10	min	at	4	 °C.	The	aqueous	 layer	was	 transferred	 to	 a	 fresh	2	ml	microfuge	 tube,	 extracted	with	 1	ml	 of	chloroform	and	divided	into	two	1.5	ml	microfuge	tubes	containing	1/10	volume	of	3	M	NaOAc	pH	5.2	and	2	volumes	of	cold	100%	EtOH	for	RNA	precipitation.	Samples	were	stored	 at	 –20	 °C.	 Prior	 to	 use,	 an	 aliquot	 of	 each	 RNA	 sample	 was	 collected	 by	centrifugation,	 quantified,	 and	 loaded	 on	 a	 1%	 agarose	 gel	 to	 assess	 RNA	 purity	 and	integrity.		
6.1.4	Primer	extension	assays			The	 oligonucleotides	 used	 for	 primer	 extension	 reactions	 are	 listed	 in	 Table	 3.	 The	primer	(5	pmol)	was	5’-end-labeled	using	6	pmol	[γ-32P]-ATP	(Perkin	Elmer)	with	T4	polynucleotide	 kinase	 (NEB)	 at	 37	 °C	 for	 45	 min.	 Unincorporated	 radiolabelled	nucleotides	 were	 removed	 with	 a	 G-25	 microspin	 column	 (GE	 Healthcare).	 Labeled	primer	(0.1	pmol)	was	then	added	to	a	mix	of	12	μg	of	total	RNA,	2	μl	of	2	mM	dNTPs	and	 2	 μl	 of	 5X	 AMV	 reverse	 transcriptase	 buffer	 (Promega)	 an	 MQ	 water	 to	 a	 final	volume	of	9.5	μl.	The	reaction	mixture	was	incubated	at	100	°C	for	3	min	and	cooled	to	42°C	before	adding	of	5	U	of	AMV	reverse	transcriptase	(Promega).	cDNA	synthesis	was	carried	 at	 42°C	 for	 60	min.	 Lather,	 samples	were	 incubated	with	 1	 μl	 of	 RNase	A	 (10	mg/ml)	for	10	min	at	room	temperature	to	remove	RNA,	extracted	once	with	an	equal	volume	of	phenol–chloroform	(1:1),	 then	ethanol	precipitated	and	resuspended	in	5	μl	of	 formamide	 loading	buffer	 (99%	 formamide,	 0.1%	bromophenol	 blue,	 10	mM	EDTA	pH	 8.0).	 After	 denaturation	 at	 100	 °C	 for	 3	 min,	 samples	 were	 subjected	 to	
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electrophoresis	on	denaturing	(6	M	urea)	6%	polyacrylamide	gels	in	TBE	buffer	(90	mM	Tris,	90	mM	boric	acid,	2.5	mM	EDTA;	pH	8.0),	dried	and	autoradiographed.				
6.1.5	Overexpression	and	purification	of	recombinant	
proteins	His6-tagged	 recombinant	 HrcA	 and	 HspR	 proteins	 were	 overexpressed	 in	
E.	 coli	 BL21	 (DE3)	 transformed	 with	 the	 plasmids	 pET15b-hrcA	 and	 pET15b-hspR	(Table	 2),	 respectively.	 Overnight	 bacterial	 cultures	 were	 diluted	 1:100	 in	 fresh	 LB	medium	and	grown	to	an	optical	density	at	600	nm	of	0.6.	Protein	overexpression	was	induced	by	addition	of	0.4	mM	isopropyl-β-D-thiogalactopyranoside	(IPTG)	and	carried	out	 for	 20	 h	 at	 20	 °C.	 Bacterial	 pellets	were	 stored	 at	 -80	 °C.	 In	 the	 case	 of	His-HrcA	purification,	 cells	 deriving	 from	 500	 ml	 cultures	 were	 resuspended	 in	 15	 ml	 of	 lysis	buffer	A	(50	mM	NaH2PO4,	pH	8.0;	300	mM	NaCl;	10	mM	imidazole;	10%	glycerol;	5mM	TCEP;	 0.5%	 Triton	 X-100)	 with	 1	 mg/ml	 of	 lysozyme	 and	 incubated	 for	 1	 h	 at	 4	 °C.	Bacterial	 cells	 were	 further	 lysed	 by	 sonication.	 The	 soluble	 protein	 fraction	 was	incubated	with	500	µl	of	pre-equilibrated	50%	Ni2+-NTA	resin	(Qiagen,	Inc.)	for	1	h	at	4	°C	on	a	 tilt-roll	apparatus.	Samples	were	washed	 five	 times	with	5	ml	of	 lysis	buffer	A	and	then	four	times	with	5	ml	of	wash	buffer	A	(50	mM	NaH2PO4,	pH	8.0;	300	mM	NaCl;	20	mM	imidazole;	10%	glycerol;	5	mM	TCEP).	His-HrcA	was	eluted	five	times	with	one	volume	of	elution	buffer	A	(50	mM	NaH2PO4,	pH8.0;	300	mM	NaCl;	250	mM	imidazole;	10%	 glycerol;	 5	 mM	 TCEP).	 3	 kDa	 MWCO	 Centricon	 ultra-filtration	 units	 (Millipore)	were	used	to	concentrate	the	protein	and	exchange	the	buffer	to	10	mM	Tris-HCl,	pH	8.0;	300	mM	NaCl;	10%	glycerol;	5	mM	TCEP;	0.05%	NP-40	[igepal].	Purified	His-HrcA	was	stored	in	aliquots	at	-80	°C.	In	regard	to	His-HspR	purification,	bacterial	cells	from	200	ml	cultures	were	resuspended	in	10	ml	of	lysis	buffer	R	(50	mM	NaH2PO4,	pH	7.5;	300	mM	NaCl;	10	mM	imidazole;	10%	glycerol;	1.5	mM	PMSF)	containing	1	mg/ml	lysozyme,	incubated	for	1	h	at	4	°C	and	then	sonicated.	The	soluble	protein	fraction	was	incubated	with	500	µl	of	pre-equilibrated	50%	Ni2+-NTA	(Qiagen,	Inc.)	for	1	h	at	4	°C	on	a	tilt-roll	apparatus.		Nonspecific	bounded	proteins	were	removed	by	washing	the	resin	five	times	with	lysis	buffer	R	and	then	four	times	with	wash	buffer	R	(50	mM	NaH2PO4,	pH	7.5;	300	mM	 NaCL;	 20	 mM	 imidazole;	 10%	 glycerol).	 His-HspR	 was	 eluted	 by	 seven	 washing	
	 53	
steps	with	one	volume	elution	buffer	R	(50	mM	NaH2PO4,	pH	7.5;	300	mM	NaCl;	250	mM	imidazole;	 10%	 glycerol).	 Finally,	 the	 recombinant	 protein	 was	 dialyzed	 against	 two	changes	 of	 footprinting	 buffer	 (50	mM	Tris-HCl,	 pH	 8.0;	 300	mM	NaCl;	 10%	 glycerol;	1mM	DTT;	0.05%	NP-40	[igepal])	and	stored	in	aliquots	at	-80	°C.		
6.1.6	DNase	I	footprinting		DNA	 radiolabeled	 probes	 (CjPcbp,	 CjPclp,	 CjPgro,	 and	 CjPhrc;	 CjPcbpWT,	 CjPcbpMHL,	
CjPcbpMHR,	and	CjPcbpMH	or	CjPgroWT,	CjPgroMHL,	CjPgroMHR,	CjPgroMH,	CjPgroMM,	and	 CjPgroML)	 used	 for	 footprinting	 experiments	 were	 obtained	 by	 labelling	 with	[γ32P]ATP	 and	 T4	 polynucleotide	 kinase	 the	 5’-end	 of	 pGEM-T-Easy-CjPcbp,	 pGEM-T-Easy-CjPclp,	 pGEM-T-Easy-CjPgro,	 pGEM-T-Easy-CjPhrc,	 pGEM-T-Easy-CjPcbpWT,	pGEM-T-Easy-CjPcbpMHL,	pGEM-T-Easy-CjPcbpMHR,	pGEM-T-Easy-CjPcbpMH,	pGEM-T-Easy-CjPgroWT,	 pGEM-T-Easy-CjPgroMHL,	 pGEM-T-Easy-CjPgroMHR,	 pGEM-T-Easy-
CjPgroMH,	 pGEM-T-Easy-CjPgroMM	 and	 pGEM-T-Easy-CjPgroML	 (Tabel	 2),	 previously	NdeI	 or	 NcoI	 digested.	 DNA	 fragments	 corresponding	 to	 the	 target	 promoter	 regions	were	 excised	 with	 second	 digestion	 with	 NcoI	 or	 NdeI	 and	 gel	 purified.	 DNA	 and	recombinant	 proteins	 were	 incubated	 for	 15	 min	 at	 room	 temperature	 in	 a	 50	 µl	reaction	volume	containing	1X	 footprinting	buffer	 (1X	FPB:	5	mM	Tris-HCl,	pH	8.0;	60	mM	NaCl;	5	mM	KCl;	5	mM	MgCl2;	0.2	mM	DTT;	0.01%	NP-40	[igepal]	and	10%	glycerol)	and	4	ng/µl	of	sonicated	salmon	sperm	DNA	as	nonspecific	competitor.	Then,	0.066	units	of	DNase	I	in	1X	FPB	containing	5	mM	CaCl2	were	added	at	the	mixture,	and	the	reaction	was	incubated	at	room	temperature	for	75	s.	The	digestion	was	stopped	adding	140	µl	of	DNase	 I	 stop	 buffer	 (192	 mM	 NaOAc,	 pH	 5.2;	 32	 mM	 EDTA;	 0.14%	 SDS;	 64	 µg/µl	sonicated	 salmon	 sperm	 DNA).	 The	 digested	 DNA	 was	 phenol-chloroform	 extracted,	ethanol	 precipitated	 and	 resuspended	 in	 13	 µl	 of	 formamide	 loading	 buffer	 (95%	formamide;	10	mM	EDTA;	0.1%	bromophenol	blue).	The	samples	were	denatured	for	5	min	 at	 100	 °C,	 chilled	 for	 1	min	 on	 ice	 and	 subjected	 to	 6%	 polyacrylamide-urea	 gel	electrophoresis.	The	gel	was	dried	and	autoradiographed.					
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6.1.7	Cross-linking	experiments		Cross-linking	 reactions	 were	 conducted	 by	 incubating	 400	 ng/µl	 CjHrcA	 or/and	 200	ng/µl	 of	 CjHspR	with	 0.005%	 glutaraldehyde	 for	 1	 h	 at	 room	 temperature,	 in	 a	 final	volume	of	15	µl.	The	reaction	was	stopped	adding	4	µl	of	SDS-loading	buffer	(SDS-LB)	and	 incubating	 the	 samples	 for	 10	min	 a	 100	 °C.	 The	 samples	were	 analysed	 by	 SDS-PAGE	and	the	proteins	detected	by	silver	staining.		
	
6.1.8	GST	pull-down	experiments		
6.1.8.1	Protein	overexpression	and	slurry	interaction	
	
E.	coli	BL21	(DE3)	strains	were	transformed	with	the	plasmids	pGEXNN	or	pGEXNN-hrcA	and	pGEXNN-hspR	 (Table	 2)	 for	 the	overexpression	of	GST	or	GST-tagged	recombinant	HrcA	and	HspR	proteins,	respectively.	Overnight	bacterial	cultures	were	diluted	1:100	in	fresh	 LB	 medium	 and	 grown	 to	 an	 optical	 density	 at	 600	 nm	 of	 0.6.	 Protein	overexpression	was	induced	by	the	addition	of	1	mM	IPTG	for	GST	and	GST-HspR	or	0.4	mM	 IPTG	 for	 GST-HrcA	 and	 carried	 out	 for	 20	 h	 at	 20	 °C.	 The	 bacterial	 pellets	 were	resuspended	in	1X	PBS,	1%	Triton	X-100,	1	mg/ml	of	lysozyme	and	incubated	for	1.5	h	at	4	°C	before	sonication.	The	soluble	protein	fraction	was	then	incubated	with	100	µl	of	GSH-Sepharose	 resin	 (Glutathione	 Sepharose®	 4B,	 GE	 Healthcare)	 for	 1h	 at	 4	 °C.	Samples	 were	 then	 washed	 four	 times	 with	 1X	 PBS	 to	 remove	 nonspecific	 protein	interactions	 and	 finally	 resuspended	 in	 100	 µl	 of	 1X	 PBS.	 The	 bound	 GST/GSH	Sepharose,	 GST-HspR/GSH	 Sepharose,	 and	 GST-HrcA/GSH	 Sepharose	 were	 quantified	thought	SDS-PAGE.	
	
6.1.8.1	GST	pull-down	analysis		An	equal	amount	of	GST/GSH	Sepharose,	GST-HspR/GSH	Sepharose	or	GST-HrcA/GSH	Sepharose	was	 incubated	with	 250	 ng/µl	 of	 purified	 recombinant	 His-HspR	 in	 a	 final	volume	of	200	µl	1X	FPB	for	1.5	h	at	4	°C.	The	samples	were	washed	seven	times	with	1X	FPB	and	the	pulled-down	proteins	analysed	by	SDS-PAGE	and	Western	blot	assay.	For	
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the	Western	blot	analysis,	the	proteins	were	separated	by	SDS-PAGE	and	blotted	onto	a	nylon	 (PVDF)	 membrane	 using	 a	 wet	 transfer	 apparatus	 (BioRad).	 The	 transfer	 was	conducted	 for	 1	 h	 at	 150	 V	 in	 transfer	 buffer	 (48	 mM	 Tris,	 39	 mM	 glycine,	 20%	methanol,	 0.037%	 SDS).	Membranes	were	 incubated	 in	 blocking	 solution	 (5%	 low-fat	milk	in	1X	PBS,	0.05%	Tween-20	or	1X	PBST)	for	1	h	at	room	temperature.	Membranes	were	 then	 rinsed	 three	 times	 for	 5	 min	 in	 1X	 PBST	 and	 incubated	 with	 the	 primary	antibody	(dilution	1:5000	of	mouse	anti-His	clone	HIS.H8	monoclonal	antibody,	Sigma	Aldrich)	 in	5%	skim	milk-1X	PBST,	 	 for	1	h	at	 room	temperature.	After	washing	 three	washings	 in	 PBST	 (1×	PBS;	 0.05%	Tween-20),	 the	membranes	were	 incubated	with	 a	1:10000	dilution	of	the	horseradish	peroxidase-conjugated	α-mouse	secondary	antibody	for	3	h	at	 room	 temperature.	Following	 three	washing	 steps	 in	PBST,	 the	 immunoblot	was	developed	by	pouring	on	the	membranes	a	solution	of	1.25	mM	luminol	containing	0.015%	 H2O2	 and	 0.068	 mM	 p-coumaric	 acid.	 The	 signal	 was	 visualized	 by	 film-autoradiography.		
6.1.9	Bacterial	Adenylate	Cyclase	Two-Hybrid	System	(BACTH)	assays	
	
E.	 coli	 BTH101	 cells	 co-transformed	 with	 pUT18C-hspR/pKT25-hspR,	 pUT18C-
hrcA/pKT25-hrcA,	 pUT18C-hspR/pKT25-hrcA,	 pUT18C-hrcA/pKT25-hspR,	 pUT18C-
hspR/pKT25,		pUT18C-hrcA/pKT25	or	pUT18C/pKT25	(tab.	2)	were	grown	on	LB	agar	plates	 added	 of	 0.5	 mM	 IPTG	 and	 40	 µg/ml	 X-gal	 (5-Bromo-4-Chloro-3-Indolyl	 β-D-Galactopyranoside)	for	1	week	at	25	°C.												
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Introduction	
	
1.1 Urease		Urease	is	an	enzyme	catalysing	the	nitrogen	organic’s	last	step	mineralization,	which	is	the	 urea	 hydrolysis,	 to	 obtain	 ammonia	 and	 carbonate,	 which	 spontaneously	decomposes	to	yield	another	molecule	of	ammonia	and	carbonic	acid	(Zambelli,	Musiani,	Benini,	&	Ciurli,	2011).	Urea	is	broadly	used	as	a	fertilizer	in	agriculture,	but	the	urease	activity	of	soil	bacteria	determines	an	ammonia	production	with	the	loss	of	the	organic	nitrogen	 source,	 and	 a	 consequent	 pH	 increase	 that	 damaged	 the	 plant	 rooting	apparatus.	Moreover,	many	pathogenic	bacteria,	such	as	Helicobacter,	Proteus,	Klebsiella,	
Pseudomonas,	and	Mycobacterium	spp.	use	this	enzyme	as	an	essential	virulence	factor	(Farrugia,	Macomber,	&	Hausinger,	2013).		
1.1.1 	Urease	as	virulence	factor			The	urease	phenotype	is	widely	distributed	across	the	bacterial	kingdom,	and	the	gene	clusters	encoding	this	enzyme	have	been	found	in	numerous	bacterial	species	(Mobley,	Island,	 &	Hausinger,	 1995).	 Among	 the	 different	 ureolytic	 bacteria,	 some	 of	 these	 are	humans	 pathogens	 commonly	 involved	 in	 infections	 of	 urinary	 and	 gastrointestinal	tracts	 (Burne	 &	 Chen,	 2000)	 (Collins	 &	 D’Orazio,	 1993).	 The	 pathogenesis	 of	 these	bacteria	 is	 closely	 related	 to	 their	ureolytc	activity,	 in	particular,	with	 the	pH	 increase	and	 the	 toxicity	 of	 released	 ammonia.	 The	 human	pathogen	H.	pylori	 can	 colonize	 the	gastric	 tract,	 eliciting	 gastritis,	 gastroduodenal	 ulcers,	 and	 cancer-induced	 by	 chronic	gastroduodenal	infections.	Although	H.	pylori	is	a	neutrophil	bacterium,	it	can	survive	in	the	acidic	environment	of	the	stomach,	thanks	to	its	urease	activity	able	to	neutralize	the	hostile	 acid	 condition	 by	 exploiting	 the	 pH	 increase	 caused	 by	 the	 urease	 mediated	ammonia	production.	This	 evidence	makes	 the	urease	a	virulence	 factor	 crucial	 at	 the	beginning	 of	 infection,	 and	 indispensable	 for	 the	 occurrence	 of	 subsequent	 host-pathogen	 interactions	 (Montecucco	&	Rappuoli,	2001).	 In	H.	pylori,	 the	majority	of	 the	acid	 resistance	 is	 given	 by	 an	 intracellular	 urease;	 its	 activity	 is	 regulated	 by	 the	availability	 of	 substrate,	 in	 turn,	 checked	 by	 the	 proton-gated	 urea	 channel	 (UreI).	
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Indeed,	UreI	is	located	in	the	bacterial	inner	membrane,	and	allows	substrate	entry	only	at	low	pH	(5.0),	when	the	channel	is	fully	open	(Weeks,	Eskandari,	Scott,	&	Sachs,	2000).	The	rapid	entry	of	urea	in	H.	pylori	cells	allows	the	massive	production	of	urea-derived	ammonia,	which	 is	 extruded	 across	 the	 inner	membrane	by	UreI	 and	 enables	 the	 fast	neutralization	of	protons	 invading	 the	periplasm	 (Scott	 et	 al.,	 2010).	 Interestingly,	 the	urease	 seems	 also	 involved	 in	 the	 nitrogen	 metabolism,	 judgment	 supported	 by	indications	 about	 the	 urea-derived	 ammonium	 assimilation	 into	 amino	 acid	 (Miller	 &	Maier,	2014).	Additionally	 to	 the	 intracellular	urease,	 this	protein	 is	also	 found	on	 the	cell	 surface	as	a	 consequence	of	bacterial	 lysis.	The	extracellular	enzyme	supports	 the	intracellular	urease	activity,	quickly	neutralizing	the	acidic	micro-environment	close	to	the	 H.	 pylori	 cells	 (Weeks	 et	 al.,	 2000).	 Moreover,	 the	 urease	 is	 also	 involved	 in	microorganism-macrophage	 interactions.	 This	 evidence	 highlights	 a	 role	 for	 this	virulence	factor	even	during	the	subsequent	stage	of	infection.	More	in	detail,	the	urease	mediated	ammonia	production	can	modulate	phagosome	pH	and	megasome	formation,	and	allows	the	H.	pylori	survival	in	macrophage	(Schwartz,	2006).	Between	the	urinary	tract	 infections,	 the	majority	 of	 clinical	 cases	 being	 associated	with	 ureolytic	 Proteus,	
Klebsiella,	 Pseudomonas,	 and	 Staphylococcus	 spp.	 (Mobley	 &	 Hausinger,	 1989).	 The	pathogen	P.	mirabilis	owns	a	urea-induced	urease	that	is	found	in	the	cytoplasm	of	the	bacterium.	 During	 infection	 in	 the	 urinary	 tract,	 the	 expression	 of	 urease,	 and	 the	subsequent	ammonia	production,	resulting	in	a	pH	increases.	The	basic	pH	in	the	local	environment	 promotes	 the	 precipitation	 of	 polyvalent	 ions	 (Mg2+	and	 Ca2+),	 normally	soluble	 in	 the	 urine,	 and	 the	 consequent	 formation	 of	 struvite	 and	 carbonate	hydroxyapatite	 crystals	 (i.e.,	 stone	 formation),	 respectively.	 Stone	 formation	 provides	several	 benefits	 connected	 to	 P.	mirabilis	 cells	 protection,	 but	 also	 to	 formation	 of	 a	nutrient-rich	environmental	niche,	tanks	to	blockage	of	urine	drainage	into	the	ureters,	protection	 from	 host	 immune	 system,	 and	 ammonia	 toxicity	 to	 host	 cells	 with	 direct	tissue	 damage	 (Coker,	 Poore,	 Li,	 &	 Mobley,	 2000).	 Differently,	 in	M.	 tuberculosis,	 the	urease	 inducted	 ammonia	 production	 is	 involved	 in	 phagosome-lysosome	 fusion	inhibition	 and	 the	 modulation	 of	 the	 phagosome	 pH.	 Moreover,	 the	 urease	 activity	resulting	 ammonia	 is	 a	 nitrogen	 source	 for	 biosynthesis	 (Clemens,	 Lee,	 &	 Horwitz,	1995).		
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1.1.2 	Urease	as	antibacterials	target		The	 idea	 to	 use	 the	 urease	 virulence	 factor	 as	 a	 novel	 target	 for	 antimicrobials	 starts	from	 the	 necessity	 to	 find	 new	 strategies	 in	 pathogen	 eradication,	 considering	 the	widespread	 bacterial	 resistance	 to	 conventional	 antimicrobial	 agents.	 Different	works	indicated	 urease	 inhibition	 as	 a	 valuable	 tool	 in	 hindering	 the	 cascade	 of	 events	 that	elicit	 the	 whole	 symptomatology	 of	 urinary	 infection	 (Kosikowska	 &	 Berlicki,	 2011).	Moreover,	 increasing	antibiotic	 resistance	compromises	also	 the	 treatment	of	H.	pylori	infection.	 In	 this	 pathogen,	 the	 urease	 targeting	 approach	 to	 eradicate	 the	 bacterium	appears	 extremely	 beneficial.	 Urease	 negative	 mutants	 are	 unable	 to	 colonize	 gastric	epithelium	(Eaton,	Brooks,	Morgan,	&	Krakowka,	1991)	(Schoep	et	al.,	2010),	and	urease	inhibition	 would	 compromise	 the	 H.	 pylori	 ability	 to	 survive	 in	 the	 stomach	 acid	environment	 and	 colonize	 the	 epithelium	 cells(Kao,	 Sheu,	 &	Wu,	 2016).	 In	 2017,	 the	World	 Health	 Organization	 (WHO)	 published	 the	 list	 of	 bacteria	 for	 which	 new	antibiotics	are	urgently	needed.	 Interestingly,	 ten	out	of	 the	twelve	antibiotic-resistant	pathogens	prioritized	are	ureolytic	bacteria.	Among	these	are	H.	pylori,	M.	tuberculosis,	C.	
neoformans,	and	Y.	pestis.	This	evidence	made	the	urease	inhibition	a	fascinating	way	to	find	novel	antibacterials	with	a	ureolytic-specific	activity.			
1.1.3 	Urease	structure			It	is	available	in	the	literature	the	characterization	at	the	molecular	level	of	the	protein	architecture	 for	 ureases	 deriving	 from	 different	 bacteria	 species	 such	 as	 Klebsiella	
aerogenes		(KAU)	(Jabri,	Carr,	Hausinger,	&	Karplus,	1995)	Sporosarcina	pasteurii	(SPU)	(Stefano	Benini	 et	 al.,	 1999)	and	H.	pylori	 (HPU)	(Ha	 et	 al.,	 2001),	 and	 from	 the	 plant	
Canavalia	 ensiformis	 (jack	 bean,	 JBU)	 (Balasubramanian	 &	 Ponnuraj,	 2010).	 These	studies	illustrate	that	in	most	bacteria	urease	(e.	g.	KAU	and	SPU)	is	structured	to	obtain	a	 trimer	 of	 trimers,	 each	 one	 composed	 of	 the	 subunits	 α,	 β	 and	 γ	(Jabri	 et	 al.,	 1995)		(Stefano	 Benini	 et	 al.,	 1999).	 Differently,	 in	H.	 pylori	 the	 β	 and	 γ	 subunits	 are	 fused;	therefore,	 the	 quaternary	 structure	 is	 composed	 of	 trimers	 of	 dimers,	 which	 are	assembled	in	a	tetrahedral	structure	harboring	a	total	of	22	active	sites	(Ha	et	al.,	2001).	Finally,	in	JBU,	the	three	bacterial	subunits	are	fused	in	a	unique	polypeptide	to	collect	a	dimer	to	omo-trimers	(Balasubramanian	&	Ponnuraj,	2010)	(fig.19).	
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Figure	 19:	 graphical	 representation	of	 ureases	 from	S.	pasteurii	 (PDB	 code:	 2USP),	(B)	K.	aerogenes	(PDB	code:	1EJZ),	(C)	H.	pylori	(PDB	code:	1E9Z)	and	(D)	jack	bean	(PDB	 code:	 3LA4).	 The	 red	 sphere	 indicates	 the	 nickel	 ions,	 while	 the	 units	 that	produce	 the	 trimer	 are	 depicted	with	 different	 colours.	 Reprinted	with	 permission	from	(Zambelli	et	al.,	2011).	Copyright	2019	American	Chemical	Society.	
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Despite	the	differences	in	the	quaternary	structure	of	the	enzyme	from	distinct	biological	sources,	 the	 catalytic	 site	 is	 strongly	 conserved	 among	bacteria	 and	plants.	 The	 catalytic	site	(fig.	20),	is	always	located	in	the	α	subunits	and	contains	two	nickel	ions,	distant	3.5	–	3.7	Å.	Each	Ni2+	is	associated	with	two	histidine	residues	and	connected	to	an	oxygen	atom	of	 a	 carbamylated	 lysine.	 Additionally,	 one	 nickel	 is	 bound	 to	 carboxylate	 oxygen	 of	aspartate,	 and	 the	 binding	 geometry	 is	 concluded	 by	 an	 H20	 bond	 to	 each	 ion	 and	 a	hydroxide	 ion	 linking	 the	 two	 metals.	 Therefore,	 one	 Ni2+	 is	 penta-coordinated	 with	 a	distorted	 square-pyramidal	 geometry	while	 the	other	Ni2+	 is	hexa-coordinated	and	has	a	distorted	 octahedral	 geometry.	 The	 tetrahedral	 cluster	 is	 concluded	 with	 one	 water	hydrogen	bond	to	constitute	 the	binding	network	 in	 the	closeness	of	 the	nickel	 ions.	The	catalytic	 site	 is	 located	 in	 a	 cavity	 able	 to	 stabilize	 the	 intermediate	 and	 the	 tetrahedral	transition	 state.	 Additionally,	 the	 protein	possesses	a	helix-turn-helix	(HTH)	mobile	flap	 essential	 for	 the	 catalytic	 activity,	which	regulates	the	entry	of	the	substrate	in	 the	 catalytic	 cavity.	 Because	 of	 this	mobility	of	 the	 flap,	 an	essential	histidine	in	 the	 HTH	motif	 swings	 of	 5	 Å	 between	the	 open	 and	 closed	 conformations	(Zambelli	et	al.,	2011).									
Figure	 20:	 Coordination	geometry	 of	 Ni2+	 on	 the	 active	site	 (A).	 The	 nickel	 is	represented	 in	 purple;	 carbon	in	 gray;	 nitrogen	 in	 blue;	oxygen	 in	 red.	 The	mobile	 flap	is	depicted	in	the	open	(B)	and	closed	 (C)	 conformation.	 In	 B	and	C	Ni2+	 ions	are	highlighted	as	 purple	 spheres.	 Reprinted	with	 permission	 from	(Zambelli	 et	 al.,	 2011).	Copyright	 2019	 American	Chemical	Society.
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1.1.4	Urease	inhibition	strategy		The	 urease	 inhibitors	 can	 be	 divided	 into	 two	 families,	 characterized	 by	 a	 different	inactivation	mechanism.	Molecules	able	to	directly	interact	with	the	Ni2+	ions	located	in	the	 catalytic	 site	 compose	 the	 first	 group.	 This	 class	 includes	 compounds	 as	 sulphite,	phosphorodiamidate,	 thiols,	phosphate,	citric,	hydroxamic	and	boric	acids	and	fluoride	(Stefano	Benini	 et	 al.,	 1999)	 (Stefano	Benini,	 Cianci,	Mazzei,	&	Ciurli,	 2014)	 (Ha	 et	 al.,	2001)	(Luca	Mazzei	et	al.,	2017).	The	second	class	of	inhibitors	blocks	the	mobility	of	the	urease	mobile-flap	that	plays	a	crucial	role	during	the	urea	catalysis.	Indeed	compounds	as	 the	 1,4-benzoquinone	 and	 the	 catechol	 directly	 interact	 with	 a	 conserved	 cysteine	located	in	the	helix-turn-helix	motif,	and	therefore	interfere	with	the	substrate	entrance	into	 the	catalytic	cavity	 (L.	Mazzei,	Cianci,	Musiani,	&	Ciurli,	2016)	 (Luca	Mazzei	et	al.,	2017).	 	 Biochemical	 information	 demonstrates	 that	 metals	 act	 as	 urease	 inhibitors	(Krajewska,	 2009).	 Metal	 ions	 are	 able	 to	 react	 with	 sulfhydryl	 of	 cysteine	 residues.	Therefore	ions	as	Hg(II),	Ag(I),	and	Cu(II)	exert	their	inactivating	function	contacting	the	Cys	located	on	the	mobile-flap.	 	 In	the	case	of	Cu(II),	the	generation	of	reactive	oxygen	species	 may	 elicit	 the	 oxidation	 of	 functional	 groups	 with	 subsequent	 urease	inactivation	 (Krajewska,	 2008).	 Moreover,	 compounds	 as	 the	 2-mercapto-ethanol	 can	inactivate	the	urease	by	both	 interacting	with	Ni2+	 ions	and	binding	the	Cys	residue	of	the	mobile-flap	(S.	Benini,	Rypniewski,	Wilson,	Ciurli,	&	Mangani,	1998).				
1.1.5	Urease	inhibitors	as	potential	drugs				Hydroxamic	 acids	 are	 considered	 the	most	widely	 studied	 group	 of	 urease	 inhibitors.	Although	the	FDA	approved	it	in	1983	to	treat	chronic	urea-splitting	urinary	infections,	the	 compound	had	 severe	 aftereffects,	 such	 as	 teratogenicity,	 psychoneurological,	 and	musculo-integumentary	symptoms	(Bailie	et	al.,	1986).	At	 the	 leader	time,	hydroxamic	amino	 acids	 and	 their	 N-substituted	 derivatives	 were	 inspected.	 N-aroyl-glycine-hydroxamic	 acids	 were	 largely	 investigated	 with	 interesting	 results	 and	 inhibitors	patented	 for	 treating	 urolithiasis	 and	 pyelonephritis.	 However,	 the	 majority	 of	 these	compounds	 were	 proven	 as	 mutagenic	 (Munakata,	 Mochida,	 Kondo,	 &	 Suzuki,	 1980).	The	amides	of	phosphoric	acid	are	the	class	of	urease	with	the	highest	urease	inhibitory	activity	 (Keerthisinghe	 &	 Blakeley,	 1995).	 Nevertheless,	 these	 inhibitors	 exhibit	 low	
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hydrolytic	 stability	 (Pope	 et	 al.,	 1998).	 Some	 non-hydrolysable	 analogous	 of	phosphoramidates,	instead,	were	determined	to	be	useful	inhibitors	of	bacterial	ureases	(Vassiliou	et	al.,	2008).	Quinones	are	an	 interesting	class	of	urease	 inhibitors	 that	also	shows	 inactivating	properties	 toward	 the	urease	 in	whole	cells	of	H.	pylori,	K.	oxytoca,	and	P.	mirabilis,	 tanks	to	the	ability	to	pass	by	membranes.	But	their	cancerogenic	and	cytotoxic	 properties	 make	 the	 group	 of	 compounds	 not	 suitable	 in	 medicine	(Kosikowska	&	Berlicki,	2011).	Polyphenols	represent	an	 intriguing	class	of	molecules,	which	 are	 highly	 bioavailable	 in	 medicinal.	 Although	 some	 of	 these	 exhibits	 only	 a	discrete	urease	inactivating	ability	(Tanaka,	Kawase,	&	Tani,	2004).		
1.2	Gold-based	drugs		Metals	and	metal-based	compounds	have	been	largely	used	as	antimicrobial	agents	for	centuries.	In	recent	years,	research	into	gold-based	drugs	for	a	range	of	human	diseases	has	seen	a	revival.	In	the	modern	pharmacology,	gold	cyanide	was	first	proposed	as	an	antitubercular	 agent.	 Successively,	 the	 therapeutic	 features	 of	 gold	 complexes	 were	widely	 investigated,	 unveiling	 its	 encouraging	 potentiality	 as	 an	 anti-arthritis,	anticancer,	 antibacterial	 and	 anti-parasitic	 (Sannella	 et	 al.,	 2008)	 (Roder	 &	 Thomson,	2015)	(Aguinagalde	et	al.,	2015).	The	clinical	practice	is	mainly	based	on	the	use	of	Au(I)	and	Au(III)	 compounds.	As	an	example,	 the	use	of	Au(I)-based	phosphirine	complexes	and	 auranofin	 [2,3,4,6-tetra-o-acetyl-L-thio-β-D-glucopyranosato-S-(triethyl-phosphine)Au(I)]	 displayed	 antibacterial	 properties	 against	 gram-positive	 and	 gram-negative	 bacteria	 (Owings	 et	 al.,	 2016)	 (Fernández,	 Vela	 Gurovic,	 Olivera,	 Chopa,	 &	Silbestri,	 2014)	 (C.	 Schmidt	 et	 al.,	 2017).	 Although	 the	 antimicrobial	 activity	 of	 these	compounds	was	demonstrated,	their	biomolecular	targets	and	mechanisms	of	action	in	bacteria	have	not	yet	been	defined.	Differently,	it	 is	known	that	their	ability	to	interact	and	 inhibit	 the	mammalian	 seleno-enzyme	 thioredoxin	 reductase	 (TrxR)	 is	 due	 to	 the	formation	 of	 Au-selenol	 in	 the	 proximity	 of	 the	 active	 site	 (Bindoli	 et	 al.,	 2009).	Concerning	 the	 Au(III)-based	 compounds,	 less	 information	 is	 available.	 Au(III)-complexes,	as	phosphorous	dendrimers	bearing	iminopyridino-end	groups	coordinating	to	Au(III)	 ions,	 showed	 inhibition	property	on	 the	 growth	of	 gram-positive	 and	gram-negative	bacteria	(Mignani	et	al.,	2017)	(Warzajtis	et	al.,	2017).			
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Aim	of	the	project		Urease	is	an	enzyme	that	plays	a	crucial	role	as	a	virulence	factor	in	the	pathogenesis	of	different	microorganisms,	 like	H.	pylori,	M.	 tuberculosis,	C.	neoformans,	Y.	pestis,	 and	P.	
mirabilis.	The	purpose	of	this	work	is	to	characterize	the	inhibition	of	different	Au(III)-based	 compounds	 on	 the	 urease	 enzyme,	 to	 investigate	 the	 potentiality	 of	 these	compounds	as	a	future	antimicrobial	in	ureolytic	bacteria.	With	this	aim,	we	implement	different	enzymatic	assays	to	obtain	a	kinetic	characterization	of	the	inhibitory	activity	of	these	Au(III)-complexes	and	to	elucidate	the	mechanism	at	the	root	of	their	capability	to	 inactivate	 the	 urease	 enzyme.	 The	 results	 obtained	 in	 this	 study	 are	 part	 of	 a	published	work	(Luca	Mazzei	et	al.,	2019).			
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Results	
		
3.1	Au(III)-based	compounds’	inhibition	on	urease	
activity		
3.1.1	Introduction	to	fast	and	slow	binding	inhibition		We	 performed	 a	 variety	 of	 enzymatic	 assays	 to	 obtain	 information	 about	 the	 inhibitory	effect	of	different	Au(III)-based	compounds	on	jack	bean	urease	(JBU).	More	in	detail,	the	following	inhibition	scheme	is	considered	(scheme	1):	
  
  
 						This	 representation	 allows	 explaining	 the	 differences	 between	 a	 fast-	 or	 slow-binding	enzyme	inhibition	model.	Indeed,	a	fast	mechanism	considers	that	the	equilibrium	between	the	 free	 enzyme	 (E)	 and	 inhibitor	 (I)	 with	 the	 enzyme-inhibitor	 complex	 (EI)	 has	association	and	dissociation	kinetic	values	(k3	and	k-3)	of	the	same	magnitude’s	order	of	the	constants	 (k1	 and	k-1)	 involved	 in	 the	equilibrium	between	 the	enzyme	and	 the	substrate	(S)	with	the	enzyme-substrate	complex	(ES).	Differently,	a	slow-binding	inhibition	may	be	explained	in	two	ways.	In	mechanism	A,	the	EI	complex	is	assembled	in	a	single	event	that	displays	k3	and	k-3	values	smaller	 if	compared	with	k1	and	k-1.	Mechanism	B	 involves	two	steps:	 an	 initial	 rapid	 formation	 of	 the	 EI	 complex	 governed	 by	 the	k3	 and	k-3	 constants,	developing	 in	a	more	 stable	E*I	 complex	 through	an	 isomerization	 step	 characterized	by	the	kinetic	constants	k4	and	k-4	(John	F.	Morrison,	1982)	(J.	F.	Morrison	&	Walsh,	1988).	It	is	possible	 to	 discern	 between	 a	 fast	 inhibition	 process	 and	 a	 slow-binding	 inhibition	
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analysing	the	evolution	of	the	substrate	consumption	(Δ[S])	over	time	(t).	The	Δ[S]/t	curve	is	linear	in	the	presence	of	a	fast	mechanism.	In	contrast,	it	exhibits	a	progression	divided	into	 three	 time-dependent	phases	 if	we	 consider	 a	 slow-binding	mechanism.	 Specifically,	the	 time-depended	 inhibition	 is	 composed	 of	 an	 initial	 linear	 phase	 occurring	when	 the	enzyme-inhibitor	 interaction	 has	 not	 been	 established,	 followed	 by	 a	 deviation	 from	linearity	 as	 a	 function	 of	 time	 proceeding	 proportionally	 with	 the	 enzyme-inhibitor	complex	 formation.	 Finally,	 the	 reaction	 arrives	 at	 a	 steady-state,	 representing	 the	equilibrium	of	 the	 system.	 Starting	 from	 the	 progress	 curves,	 it	 is	 possible	 to	 obtain	 the	initial	velocity	of	the	reaction	(!!)	which	is	the	slope	of	the	curve	in	the	initial	linear	phase,	and	the	steady-state	velocity	(!!)	as	the	slope	of	the	last	phase	(John	F.	Morrison,	1982)	(J.	F.	 Morrison	 &	 Walsh,	 1988).	 Differently,	 if	 we	 consider	 the	 two-step	 isomerization	mechanism	 (scheme	1,	mechanism	B)	 the	!! 	derived	 from	 the	EI	 complex	 formation,	 and	the	!!	is	the	consequence	of	the	affinity	for	the	final	complex	E*I	(Copeland,	2013).			
3.1.2	Au(III)-based	compounds	inhibit	urease	with	a	slow-
binding	mechanism		Based	on	the	previously	described	information,	we	performed	progress	curve	experiments	of	urea	hydrolysis	at	increasing	concentration	of	Au(III)-based	inhibitors	(fig.21)	to	monitor	the	 substrate	 consumption.	 In	 our	 system,	 ammonia	 formation	 consequent	 to	 urea	degradation	determines	a	change	in	absorbance	elicited	to	the	pH	increase.					
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Figure	 21:	 Schematic	 representation	 of	 the	 Au(III)-based	 compounds	 tested	 as	urease	inhibitors;	(A)	AuC^N^N,	(B)	MNW033,	(C)	MNW034,	(D)	MNW102,	and	(E)	MNW107.		The	 obtained	 progress	 curves	 (fig.22)	 demonstrate	 the	 ability	 of	 all	 tested	 Au(III)-complexes	 to	 inhibit	 the	 urease	 enzyme,	 and	 exhibit	 a	 clear	 deviation	 from	 linearity;	 this	indicates	 that	 the	 interaction	 between	 JBU	 with	 all	 compounds	 involves	 a	 slow-binding	mechanism.	The	collected	curves	revealed	an	initial	very	short	linear	phase	that	evolved	by	an	intermediate	step	to	reach	the	steady-state.	Unfortunately,	since	the	initial	linear	phase	is	too	 brief,	 it	 was	 not	 possible	 to	 obtain	 precise	 substrate	 consumption	 curves	 with	 our	equipment,	 and	 a	 consequent	 kinetic	 characterization	 of	 inhibition	 starring	 with	 this	enzymatic	assay.		Although	the	reported	data	are	not	sufficient	to	obtain	an	accurate	kinetic	characterization	 of	 the	 tested	 inhibitors	modality,	 any	 consideration	 is	 possible.	 Indeed,	 a	higher	inhibitor	concentration	is	required	for	the	A	and	E	compounds,	if	compared	with	the	C	and	D	 inhibitors,	whereas	an	 intermediate	concentration	 is	needed	 for	 the	B	compound.	These	 results	 highlight	 that	 the	 formation	 of	 the	 E*I	 complex	 is	 faster	 for	 the	 C	 and	 D	molecules	and	slowest	in	the	presence	of	A	and	E.			
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E	
 
Figure	22:	 Progress	 curve	 plots	 of	JBU	 with	 different	 concentration	 of	 (A)	AuC^N^N,	 (B)	 MNW033,	 (C)	 MNW034,	(D)	 MNW102,	 and	 (E)	 MNW107	determined	 by	 progress	 curve	experiments.		
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3.1.3	Evaluation	of	the	Ki	and	Ki*		In	the	two-step	isomerization	mechanism,	the	apparent	values	of	Ki		(k3/k-3)	and	Ki*		(k4/k-4)	were	 recovered	 from	 the	 concentration-response	 plots	 of	 the	 initial	 and	 finally	 inhibited	states	 respectively	 (Copeland,	 2013).	 Furthermore,	 considering	 the	 non-competitive	modality	 proposed	 for	 these	 Au(III)-base	 inhibitors,	 the	 apparent	 Ki	 and	 Ki*	 can	 be	considered	 as	 the	 true	 Ki	 and	 Ki*.	 The	 Ki	 of	 different	 compounds	 were	 obtained	 (tab.4),	starting	 from	 the	!! 	values	measured	 using	 the	 initial	 rate	 experiments.	 Thus	 the	 residual	activity	 calculated	 as	!!/!!		 (where	!!	is	 the	 reaction	 velocity	 in	 the	 absence	 of	 inhibitor)	was	plotted	as	a	function	of	inhibitor	concentration	(fig.	23)	and	fitted	with	the	equation	1.	
																																																			 							Eq.	1	
	
	
Figure	 23:	 Concentration-response	 plots	 of	 the	 initial	 inhibited	 state	 of	 JBU	 with	Au(III)-based	compounds,	 (A)	AuC^N^N,	(B)	MNW033,	 (C)	MNW034,	 (D)	MNW102	and	(E)	MNW107.		
	
Table	4.:	Ki*	values	obtained	for	the	Au(III)-based	inhibitors	with	JBU.	
	 	
trations of inhibitor. The apparent values of Ki and of K i* can therefore be obtained
as the IC50 s of the isotherms for vi/v0 and for vs/v0 , respectively, as illustrated in 
Figure 6.7:
(6.8)
and
(6.9)
Note that for very slow binding inhibitors that are studied by varying preincubation
time, the fits of the exponential decay curves to Equation (6.4) provide values for
both vi and kobs for each inhibitor concentration. The values of vi at each inhibitor
concentration represent the y-intercepts of the best fit to Equation (6.4), and these
can be used in conjunction with Equation (6.8) to obtain an independent estimate of
Kiapp.
The form of Equation (6.7) reveals an interesting aspect of slow binding
inhibiton due to enzyme isomerization. A slow forward isomerization rate is insuf-
ficient to result in slow binding behavior. The reverse isomerization rate must also
be slow, and in fact must be significantly slower that the forward isomerization rate.
If this were not the case, there would be no accumulation of the E*I conformation
at equilibrium. As the value of k6 becomes >> k5, the denominator of Equation (6.7)
approaches unity. Hence the value of K i* approaches Ki, and one therefore does not
observe any time-dependent behavior.
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Figure 6.7 Concentration–response plots for the initial (A) and final (B) inhibited states of an
enzyme reaction inhibited by a slow binding inhibitor that conforms to the mechanism of scheme C of
Figure 6.3. The values of vi and vs at each inhibitor concentration were obtained by fitting the data in
Figure 6.6A to Equation (6.1). These were then used to calculate the fractional velocity (vi/v0 in panel
A and vs/v0 in panel B), and the data in panels A and B were fit to Equations (6.8) and (6.9) to obtain
estimates of Kiapp and Ki*app, respectively.
E D 
A B C 
 !!	(µM)	
	 	
AuC^N^N	 18.6	±	0.8	
MNW033	 7.2	±	0.4	
MNW034	 13	±	1	
MNW102	 22	±	3	
MNW107	 1.41	±	0.06		
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Differently,	 the	Ki*	was	 characterized	 by	 pre-incubation	 experiments.	 This	 assay	 allows	 to	obtain	the	!!	that	is	the	velocity	of	the	reaction	after	a	pre-incubation	time,	that	is	the	time	required	to	reach	the	equilibrium	of	the	final	E*I	complex,	spacing	between	40’	and	8	h.	Then	the	 residual	 activity	 in	 the	 steady-state	 (!!/!!)	was	 used	 to	 obtain	 the	 concentration-response	plots	 (fig.	 24).	 Finally,	 the	Ki*	 values	 (tab.	 5)	 are	extracted,	 fitting	 the	data	with	
equation	2.		
																																																			 							Eq.	2	
	
	
Figure	24:	Concentration-response	plots	of	the	final	inhibited	state	of	JBU	with	Au(III)-based	 compounds,	 (A)	AuC^N^N,	 (B)	MNW033,	 (C)	MNW034,	 (D)	MNW102	and	 (E)	MNW107.		
	
Table	5:	Ki	values	obtained	for	the	Au(III)-based	inhibitors	with	JBU.		Interestingly,	al	the	tested	compound	show	a	strong	inactivating	ability	with	Ki*	values	in	the	 low	 nanomolar	 concentration	 range.	 This	 result	 highlights	 the	 marked	 inhibiting	activity	of	A(III)-	based	compounds.		
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can be used in conjunction with Equation (6.8) to obtain an independent estimate of
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The form of Equation (6.7) reveals an interesting aspect of slow binding
inhibiton due to enzyme isomerization. A slow forward isomerization rate is insuf-
ficient to result in slow binding behavior. The reverse isomerization rate must also
be slow, and in fact must be significantly slower that the forward isomerization rate.
If this were not the case, there would be no accumulation of the E*I conformation
at equilibrium. As the value of k6 becomes >> k5, the denominator of Equation (6.7)
approaches unity. Hence the value of K i* approaches Ki, and one therefore does not
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Figure 6.7 Concentration–response plots for the initial (A) and final (B) inhibited states of an
enzyme reaction inhibited by a slow binding inhibitor that conforms to the mechanism of scheme C of
Figure 6.3. The values of vi and vs at each inhibitor concentration were obtained by fitting the data in
Figure 6.6A to Equation (6.1). These were then used to calculate the fractional velocity (vi/v0 in panel
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Discussion	
	The	 five	 Au(III)-based	 compounds	 (AuC^N^N,	 MNW033,	 MNW034,	 MNW102,	 and	MNW107)	 analysed	 in	 this	 study	 can	 inhibit	 the	 urease	 enzyme.	 The	 progress	 curves	results	 elucidate	 as	 the	 inhibition	modality	 is	based	on	a	 slow-binding	mechanism.	The	initial	 rate	 experiment	 with	 the	 pre-incubation	 measures	 indicates	 a	 time-dependent	inhibition	based	on	a	 two-step	 isomerization	mechanism;	 this	evidence	 is	 supported	by	the	SPU	X-ray	structure	obtained	from	the	urease	inactivated	by	the	MNW034	compounds	(Luca	Mazzei	 et	 al.,	 2019).	 Indeed,	 the	 structure	 reveals	 the	 presence	 of	 two	Au	 atoms	located	 in	 the	proximity	 of	 the	mobile	helix-turn-helix	motif	 (Luca	Mazzei	 et	 al.,	 2019).	This	data,	on	the	one	hand,	elucidate	the	basis	of	the	compounds	mediated	inhibition	as	attributable	to	the	disturbance	of	the	mobile	flap	action	that	is	fundamental	for	the	urease	activity.	 On	 the	 other	 hand,	 the	 lack	 of	 the	 organic	 ligand	 suggests	 a	 succession	 of	different	 steps	 to	 obtain	 the	 compound-urease	 substitution	 and	 supports	 the	 kinetic	results	 displaying	 the	 existence	 of	 an	 initial	 EI	 complex	 evolving	 in	 a	 more	 stable	 E*I	complex.	In	the	case	of	the	bidentate	N^N	coordination	compound,	the	EI	complex	may	be	explained	by	non-covalent	gold-complex/urease	interactions,	responsible	for	the	Ki	at	the	initial	 inhibited	 state.	 Whereas	 the	 two	 Au	 ions	 bound	 to	 the	 Cys-His-Met	 urease’s	residues	 (Luca	 Mazzei	 et	 al.,	 2019)	 represent	 the	 E*I	 complex	 and	 produce	 the	 final	inactivated	 state	 characterized	 by	 the	 Ki*.	 Differently,	 the	 E*I	 complex	 obtained	 after	urease	inhibition	with	other	Au(III)-based	compounds	is	not	yet	characterized,	and	may	contemplate	retention	of	the	cyclometallated	ligands	(Wenzel	et	al.,	2018)	(Luca	Mazzei	et	al.,	2019).	Among	those	tested	in	this	study,	the	cationic	organic	coordination	compound	(MNW034)	exhibits	the	highest	inhibitory	activity.	In	contrast,	the	other	neutral	bidentate	N^N	compound	(MNW102)	shows	a	lower	inhibitory	efficiency	as	compared	with	the	two	C^N	 coordinating	 complexes	 (MNW033	 and	 MNW107).	 The	 Au(III)	 C^N^N	 complex	displays	the	least	inhibition	property,	in	agreement	with	its	previously	characterized	low	reactivity	 with	 other	 proteins	 (Meier,	 Gerner,	 Keppler,	 Cinellu,	 &	 Casini,	 2016).	 The	difference	 in	 efficacy	 between	 the	 two	 bidentate	 N^N	 compounds	 MNW034	 and	MNW102,	cationic	and	neutral	respectively,	suggests	a	role	as	driving	force	in	the	initial	phase	 for	 electrostatic	 interactions,	which	 take	place	 between	 the	urease	 and	 the	 gold-complex,	and	are	probably	involved	in	the	promotion	of	the	Au(III)	coordinative	binding	(Graziani	et	al.,	2017)	(Luca	Mazzei	et	al.,	2019).			
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Conclusions		This	work	highlights	the	potentiality	of	gold-based	drugs	to	inhibit	the	urease	enzyme,	a	virulence	factor	founded	in	a	large	variety	of	microorganisms,	thanks	to	their	ability	to	inactivate	the	enzyme	in	the	low	nanomolar	concentration	range.	In	2017,	ten	out	of	the	twelve	 antibiotic-resistant	 pathogens	 prioritized	 by	 the	 World	 Health	 Organization	(WHO)	for	research	of	new	antimicrobial	strategies	are	ureolytic	bacteria.	Among	these	are	 H.	 pylori,	 M.	 tuberculosis,	 C.	 neoformans,	 and	 Y.	 pestis.	 Concluding,	 the	 promising	results	 illustrated	 in	 this	 work	 can	 serve	 as	 an	 attractive	 starting	 point	 for	 future	additional	optimizations	of	 the	 investigated	gold	compounds	to	obtain	novel	ureolytic-specific	antibacterials.								
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Materials	and	methods	
	
6.1.1	Enzyme	and	inhibitor	sources	
	
Canavalia	 ensifomis	 (jack	 bean)	 urease	 (JBU)	 (Mr	 =	 250	 kDa)	 C-3	 powder	 (≥	 600,000	units/g)	was	purchased	from	Sigma-Aldrich	SRL	(St.	Louis,	MO).	Enzyme	quantification	was	 carried	 out	 by	 measuring	 urease	 activity	 at	 pH	 7.0	 through	 a	 pH-STAT	 method	(Stefano	Benini,	Gessa,	&	Ciurli,	1996),	and	considering	the	specific	activities,	JBU	equal	3500	units	(Krajewska,	2009).	The	inhibitors	are	synthetized	by	the	laboratory	of	Prof.	Angela	 Casini,	 Chair	 of	 Medicinal	 and	 Bioinorganic	 Chemistry,	 School	 of	 Chemistry,	Cardiff	University,	Park	Place,	CF10	3AT	Cardiff	(United	Kingdom).		
6.1.2	Kinetics	measurements		The	experiments	were	performed	at	room	temperature	by	using	a	spectrophotometric	assay	 and	 an	 Agilent	 Cary	 60	 UV−vis	 spectrophotometer.	 The	 measurements	 were	performed	in	a	cresol	red	buffer	solution	(CR)	containing	2	mM	HEPES	buffer,	at	pH	7.5,	and	 30	 mg	 L-1	 of	 cresol	 red,	 the	 latter	 being	 used	 as	 a	 pH	 indicator	 to	 monitor	 the	increase	in	pH	over	time	due	to	urease	activity.	All	solutions	were	treated	with	CHELEX®	resin	 (sodium	 form,	 50-100	 mesh,	 dry,	 Sigma	 Aldrich),	 following	 the	 manufacturer’s	instructions,	 in	 order	 to	 remove	 any	 trace	 of	metal	 ions	 that	 could	 interfere	with	 the	enzymatic	 activity	 measurements.	 Stock	 solutions	 of	 compounds	 1-5	 (10	 mM)	 were	prepared	by	dissolving	the	powder	in	DMSO;	2	mM	HEPES	buffer,	at	pH	7.5	was	used	for	further	 dilutions.	 Different	 concentrations	 of	 compounds	 1-5,	 in	 the	 range	 0-400	 nM,	were	added	to	a	1	nM	JBU	solution	dissolved	in	CR	buffer.		
	
6.1.2.1	Progress-curves	assays			The	 experiments	 were	 started	 adding	 an	 enzyme	 and	 inhibitor	 solution	 to	 a	concentrated	solution	of	 substrate	urea	 to	reach	a	 final	concentration	of	100	mM.	The	change	in	absorbance	at	573	nm,	due	to	the	pH-dependent	change	in	the	color	of	cresol	red,	was	monitored	over	time	every	10	s.	
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6.1.2.2	Initial	rate	experiments		The	 experiments	 were	 started	 adding	 an	 enzyme	 and	 inhibitor	 solution	 to	 a	concentrated	solution	of	 substrate	urea	 to	reach	a	 final	concentration	of	100	mM.	The	change	in	absorbance	at	573	nm,	due	to	the	pH-dependent	change	in	the	color	of	cresol	red,	 was	monitored	 at	 different	 times.	 For	 each	 concentration	 of	 inhibitor,	 the	 initial	reaction	 rate	 (vi)	 was	 calculated	 as	 the	 slope	 of	 the	 linear	 portion	 of	 the	 absorbance	versus	time	curves.	The	resulting	values	were	normalized	on	the	initial	reaction	rate	in	the	 absence	 of	 inhibitor	 (v0),	 and	 the	 obtained	 percentage	 residual	 activity	 (RA,	 %)	values	were	plotted	as	a	function	of	the	inhibitor	concentration.	
	
6.1.2.3	Pre-incubation	experiments		After	an	appropriate	incubation	period	(1-8	h),	used	for	the	enzyme–inhibitor	complex	to	reach	a	steady-state	condition,	 the	experiments	were	started	upon	the	addition	of	a	concentrated	 solution	 of	 substrate	 urea	 to	 the	 incubation	 solution	 to	 reach	 a	 final	concentration	 of	 100	 mM.	 The	 change	 in	 absorbance	 at	 573	 nm,	 due	 to	 the	 pH-dependent	change	 in	 the	color	of	 cresol	 red,	was	monitored	over	 time	every	10	s.	For	each	concentration	of	inhibitor,	the	initial	reaction	rate	(vi)	was	calculated	as	the	slope	of	 the	 linear	 portion	 of	 the	 absorbance	 versus	 time	 curves.	 The	 resulting	 values	were	normalized	on	the	initial	reaction	rate	in	the	absence	of	inhibitor	(v0),	and	the	obtained	percentage	 residual	activity	 (RA,	%)	values	were	plotted	as	a	 function	of	 the	 inhibitor	concentration.	
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